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ABSTRACT 
  
 Human breast milk is the gold standard for infant nutrition. In human milk, the 
oligosaccharides may protect babies by acting as decoy receptors for pathogens. Also, human 
milk oligosaccharides (HMOs) enhance the proliferation of probiotics to strengthen the host 
immune system. Among HMOs, 2’-fucosyllactose (2-FL), composed of L-fucose and D-lactose, 
is known to possess an anti-infection capability against many harmful organisms such as 
Campylobacter jejuni, enteropathogenic Escherichia coli, and even Norovirus. Consequently,  
great quantities of 2-FL are being demanded for food applications and thorough investigation of 
its biological properties. The current synthetic methods of 2-FL including chemical production 
and enzymatic catalysis are complicated, expensive, and thus impractical for a large-scale 
synthesis. In my research study, an alternative route to produce 2-FL using a microbial cell 
factory was devised. First, E. coli, as a host strain to produce 2-FL, was engineered to 
overexpress genes in the metabolic pathway of GDP-L-fucose, a donor of L-fucose, and harbor 
the fucosyltransferase enzyme (FucT2) which catalyzes the transfer of L-fucose onto a lactose 
molecule enabling 2-FL production. Second, the production conditions of 2-FL in the engineered 
E. coli were optimized in order to pinpoint the appropriate conditions promoting the efficient and 
consistent synthesis of 2-FL. Third, the key enzyme in 2-FL production, FucT2, from different 
sources was compared in search for the FucT2 leading to an enhanced synthesis of 2-FL. Fourth, 
the possibility to produce 2-FL was demonstrated in a different host, Saccharomyces cerevisiae, 
which is a generally recognized as safe (GRAS) organism. Through metabolic engineering, the 
minimum three components required to construct a 2-FL-producing S. cerevisiae consisting of 
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GDP-L-fucose production, lactose internalization, and functional expression of FucT2 were 
confirmed. Additionally, the gene target perturbation, deletion of GDA1, which resulted in an 
improved production of GDP-L-fucose was identified. GDP-L-fucose is a beneficial sugar 
nucleotide which serves as a precursor to innumerable compounds aside from 2-FL. From this 
study, the feasibility and scalability of employing the microbial cell factory approach for 2-FL 
and GDP-L-fucose production were manifested.  
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1.1 Human milk oligosaccharides structure and health benefits 
 Human breast milk is the best source of nutrition for newborns. In addition to nutrients, it 
provides immunological components important for infant growth and development. 
Breastfeeding provides numerous health benefits to babies including but not limited to a lower 
incidence of infectious diarrhea caused by pathogens, a decreased risk of common autoimmune 
diseases, such as celiac disease, protection against excessive inflammation, faster brain 
development, a reduced risk of asthma, and decreased dental problems (Walker, 2010). 
Human milk is composed mainly of lactose, lipids, proteins, and oligosaccharides other 
than lactose (Fig. 1.1). Human milk oligosaccharide (HMO), the third most abundant element, 
has received much attention in the past decade owing to its prebiotic property stimulating the 
growth of select beneficial gut microorganisms and inhibitory effect against pathogen adhesion 
to intestinal cells (Kunz et al., 2000; Morrow et al., 2004; Newburg et al., 2004). The structure of 
HMOs is based on a lactose backbone which can be further elongated by N-acetylglucosamine, 
L-fucose, or sialic acid to form a more complex oligosaccharide (Han et al., 2012). The most 
copious type of HMOs is the fucosylated (L-fucose containing) type constituting over 70% of 
total HMOs (Ninonuevo et al., 2006).  
2’-fucosyllactose (2-FL) is the most prevalent fucosylated HMO accounting for about 
30% of total HMOs in 2-FL-secreting mothers (Chaturvedi et al., 2001; Morrow et al., 2005). It 
plays a crucial role in guarding the host from biological harm such as microbial cells and toxins. 
The enteric pathogen Campylobacter jejuni binds to soluble 2-FL (acting as a receptor analog for 
pathogens) before binding to the epithelial cells and gets swept away with 2-FL without infecting 
the host (Chaturvedi et al., 2001; Morrow et al., 2004). In a recent finding, 2-FL synthesized by 
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whole-cell biocatalysis inhibited the adhesion of not only C. jejuni but also enteropathogenic E. 
coli, Salmonella enterica serovar Fyris, and Pseudomonas aeruginosa to the intestinal human 
cell line Caco-2 (reduction of 26%, 18%, 12%, and 17%, respectively) (Weichert et al., 2013). 
Protecting against viral pathogenesis, 2-FL was reported to block the attachment of Norovirus to 
host receptor glycans (Shang et al., 2013). Moreover, 2-FL exhibits a bifidogenic effect 
specifically boosting the growth of Bifidobacterium bifidum and B. longum subsp. infantis 
leading to a superior gut health (Asakuma et al., 2011). 
 
1.2 Current approaches to produce 2’-fucosyllactose 
 Due to its various benefits, improved methods for production of 2-FL is needed in order 
to further evaluate its biological functions and to enable food applications such as incorporation 
in infant formula. Current access to 2-FL is limited because of the high cost of 2-FL in the 
market (roughly $100 per mg) which hinders the extension of 2-FL research. To obtain 2-FL, 
human milk is extensively purified, or methods of chemical or enzymatic synthesis are available. 
While there are many approaches for producing 2-FL, the current processes pose several 
disadvantages (Han et al., 2012). Isolation of 2-FL from human milk requires several steps of 
purification which results in the overall lengthy production time and makes this technique 
impractical for a large-scale production. Chemical synthesis of 2-FL can be accomplished 
through chemical reactions, however, the use of toxic reagents is involved during the process, the 
yield of the end product is low, and the complete operation can be rather expensive. To produce 
2-FL via the enzymatic route, the present shortcomings are high costs of substrate and enzyme 
purification.   
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1.3 Production of 2’-fucosyllactose using a microbial cell factory through metabolic 
engineering 
 Metabolic engineering is the term used for targeted alteration of metabolic pathways in 
an organism in order to utilize cellular metabolism for production of a desired compound 
(Lessard, 1996). Modification of cellular processes involves the use of recombinant DNA 
techniques to express new genes in host cells, amplify endogenous enzymes, or knock out genes 
or modulate enzyme activities (Nielsen, 1998). The chemical reaction of 2-FL synthesis requires 
an activity of the enzyme α-1,2-fucosyltransferase (FucT2) catalyzing the transfer of L-fucose 
from GDP-L-fucose to the acceptor, D-lactose (Albermann et al., 2001). To enable the cells to 
produce 2-FL, substrates (GDP-L-fucose and lactose) must be intracellularly available for 
converting to the product. GDP-L-fucose may be obtained through an in vivo metabolic 
conversion from GDP-L-mannose (de novo pathway) (Ginsburg, 1960, 1961a,b) or L-fucose 
supplied from an external source or emancipated from catabolism of fucosylated glycans in the 
lysosome followed by an in vivo enzymatic conversion (salvage pathway) (Coffey et al., 1964; 
Kaufman and Ginsburg, 1968) (Fig. 1.2). The de novo pathway involves two enzymatic reactions 
of GDP-D-mannose-4, 6-dehydratase (GMD) and GDP-4-keto-6-deoxymannose-3, 5-epimerase-
4-reductase (WcaG or FX) (Byun et al., 2007; Tonetti et al., 1996). In the salvage pathway, L-
fucose provided extracellularly is internalized by L-fucose permease (FucP) and/or L-fucose 
released from the lysosome is transported to the cytosol. Then, an activity of the bifunctional 
enzyme, L-fucose kinase/L-fucose-1-phosphate guanylyltransferase (FKP), is required for the 
conversion of L-fucose to GDP-L-fucose (Coyne et al., 2005). The second substrate, lactose, can 
be fed into the cells to allow the product conversion. Another indispensable element, the enzyme 
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FucT2, should be well expressed in the cytosol in order to facilitate the fucosylation of lactose 
yielding 2-FL synthesis. There are several putative FucT2 from different organisms. FucT2 from 
Helicobacter pylori has been the most extensively studied and shown to be functionally 
expressed in E. coli (Ma et al., 2006). Via the metabolic engineering approach, development of a 
cost-effective method of producing 2-FL directly from an inexpensive sugar, lactose, is 
attainable using the microbial cell as a manufacturing factory. This approach is also scalable by 
increasing the size of operation to a larger fermenter. 
 
1.4 Metabolic engineering of Escherichia coli for 2’-fucosyllactose production 
E. coli is an attractive choice as a host to produce a target metabolite due to the wide 
access of its genetic tools and ease of culture. To produce 2-FL in E. coli, we first need GDP-L-
fucose. E. coli naturally possesses the de novo and salvage pathways for synthesizing GDP-L-
fucose, because GDP-L-fucose is a precursor for the formation of colanic acid, an 
exopolysaccharide component found in Enterobacteriaceae (Stevenson et al., 1996). However, 
metabolic engineering techniques may be applied to increase the intracellular concentration of 
GDP-L-fucose. In regard to lactose, lactose can be made available inside the cells by lactose 
uptake from the medium. E. coli normally ferments lactose regulated by the lac operon 
consisting of a lactose permease (LacY) and a β-galactosidase (LacZ), which hydrolyzes lactose 
into glucose and galactose. Yet, intact lactose is needed for 2-FL production. Metabolic 
engineering strategies again may come into play to reserve more lactose for 2-FL synthesis, or 
sourcing for a strain which is inefficient in lactose utilization can also benefit 2-FL formation. In 
terms of FucT2, most laboratory E. coli strains do not express FucT2, though some other strains 
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in nature like E. coli O126 (Engels and Elling, 2014) and O128 (Shao et al., 2003) do. 
Accordingly, introduction of the functionally-expressed FucT2 in laboratory E. coli strains is 
necessary.   
 
1.5 Previous endeavors on 2’-fucosyllactose production in the engineered E. coli 
 Drouillard et al. (2006) attempted to eliminate the competing pathway for 2-FL 
production by preventing colanic acid production from GDP-L-fucose. Hence, the recombinant 
E. coli was engineered to disrupt the enzyme colanic acid biosynthesis UDP-glucose lipid carrier 
transferase (WcaJ) which utilizes GDP-L-fucose for colanic acid formation. To increase the flux 
from the central metabolism toward the GDP-L-fucose pathway, the positive regulator protein of 
the colanic acid operon, RcsA, was overexpressed. In addition, the β-galactosidase (LacZ) 
enzyme which breaks down lactose into glucose and galactose was deactivated to preserve intact 
lactose for 2-FL formation. By supplementing 15 g/L of lactose to the growth medium, the 
recombinant E. coli was able to produce 11 g/L of 2-FL extracellularly.  
More recently, Baumgartner et al. (2013) aimed to enhance the intracellular availability 
of GDP-L-fucose by chromosomally integrating additional copies of the enzymes associated 
with the de novo and salvage routes for GDP-L-fucose formation. Moreover, two copies of the 
FucT2 gene were integrated into the genome to gain a strong fucosylating activity. The resulting 
recombinant E. coli produced 20.28 g/L of 2-FL in the glycerol-limited fed-batch fermentation.  
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1.6 Metabolic engineering of Saccharomyces cerevisiae for GDP-L-fucose and 2’-
fucosyllactose production 
S. cerevisiae has a long history in alcoholic fermentations and baking. Through those 
practices, knowledge of this yeast about genetics, physiology, and biochemistry as well as 
molecular biology tools and techniques has compiled over time (Nevoigt, 2008). The U.S. Food 
and Drug Administration (FDA) classified S. cerevisiae as GRAS (generally recognized as safe) 
in 1986, which draws attention of this yeast to more food applications.  
In regard to GDP-L-fucose and 2-FL production, S. cerevisiae could be a great host 
organism for this purpose for a few reasons. It has a large intracellular pool of GDP-D-mannose, 
a precursor for GDP-L-fucose synthesis, because it performs significant mannosylation such as 
adding mannose residues to proteins (Mattila et al., 2000). The fact that it does not contain a 
pathway for GDP-L-fucose biosynthesis may also be advantageous. GDP-L-fucose becomes a 
dead-end molecule that can then be totally concentrated on 2-FL formation without deviating to 
other metabolic pathways. Being considered as a safe organism, yeast secreting 2-FL can have a 
bright future in various perspectives such as food applications. 
GDP-L-fucose production in S. cerevisiae can be accomplished via either de novo or 
salvage routes. The de novo approach necessitates expressions of heterologous GMD and WcaG 
to transform inherent GDP-D-mannose into GDP-L-fucose (Mattila et al., 2000; Nakayama et al., 
2003). For the salvage mode, the sole expression of exogenous FKP complements the conversion 
of L-fucose to GDP-L-fucose when L-fucose is extracellularly supplemented (Liu et al., 2011). 
To further enable S. cerevisiae to produce 2-FL, at least two more steps have to be 
executed aside from the intracellular synthesis of GDP-L-fucose. First, the cytosolic activity of 
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FucT2 is needed to permit the fucosylation of lactose for 2-FL formation. S. cerevisiae does not 
natively express FucT2. Therefore, the functional FucT2 from foreign organisms is required to 
be incorporated in the yeast. Second, the availability of lactose inside the cells is mandatory. 
Nevertheless, wild-type S. cerevisiae cannot assimilate lactose which makes it impossible to 
supply lactose in the cytosol. To correct this defect, the recombinant S. cerevisiae expressing a 
lactose transporter and the enzyme β-galactosidase from naturally lactose-consuming organisms 
like Kluyveromyces species, can be constructed (Sreekrishna and Dickson, 1985). The elements 
discussed above are prerequisites in generating a yeast strain platform for producing 2-FL. 
However, additional metabolic engineering actions may need to be implemented to acquire the 
actual 2-FL-producing yeast.  
 
1.7 Previous endeavors on GDP-L-fucose and 2’-fucosyllactose production in the 
engineered S. cerevisiae 
Mattila et al. (2000) constructed the S. cerevisiae strain harboring the E. coli de novo 
GMD and WcaG enzymes. The resulting strain produced 0.2 mg/L of GDP-L-fucose from innate 
GDP-D-mannose. By externally supplementing GDP-D-mannose, the amount of synthesized 
GDP-L-fucose was raised 3-fold as compared with the one without the supplementation. The 
author also affirmed the successful formation of GDP-L-fucose by performing the α-1,3-
fucosyltransferase assay. The crude extract of the yeast expressing GMD and WcaG was used as 
the source of GDP-L-fucose in the assay reaction. The product, sialyl-Lewis X, was detected in 
the reaction after incubation with the acceptor molecule, sialyllactosamine, for one hour.  
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The same research group, Jarvinen et al. (2001), reported another GDP-L-fucose 
synthesis in S. cerevisiae from the expression of enzymes originated from H. pylori, GMD and 
GMER (WcaG in E. coli). The S. cerevisiae engineered with the H. pylori enzymes was able to 
synthesize 5 µmol/mL of GDP-L-fucose. Moreover, the fucosyltransferase assay similar to the 
previous work was conducted to verify the production of GDP-L-fucose. The α-1,3-fucosylated 
glycan product was observed at the end of the assay indicating the presence of L-fucose donor, 
GDP-L-fucose. 
Later in 2003, Nakayama et al. expressed the GDP-L-fucose synthesizing genes from 
Arabidopsis thaliana, MUR1 and GER1, which are equivalent to the E. coli GMD and WcaG, 
respectively, in S. cerevisiae. The functional expression of the two genes was achieved which 
capacitated the yeast to accumulate 0.002 mg/2x108 cells of GDP-L-fucose in vivo. 
Through a distinct route, Liu et al. (2011) successfully demonstrated the heterologous 
expression of FKP, the salvage pathway enzyme, from Bacteroides fragilis in S. cerevisiae. The 
recombinant S. cerevisiae was able to synthesize 0.13 mg of GDP-L-fucose in a 25 ml culture 
when 15 mM L-fucose was provided in the medium.  
Although GDP-L-fucose formation in S. cerevisiae is certain, no article regarding 2-FL 
production in yeast has been published to date.  
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1.8 Figures 
 
 
Fig. 1.1 Human milk composition (Zivkovic et al., 2011). 
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Fig. 1.2 GDP-L-fucose biosynthesis. The multi-step reactions on the left are the salvage pathway 
and the reactions on the right are the de novo pathway. FUK encodes L-fucose kinase. GFPP 
encodes GDP-L-fucose pyrophosphorylase. GMD encodes GDP-D-mannose-4, 6-dehydratase. 
WcaG encodes GDP-4-keto-6-deoxymannose-3, 5-epimerase-4-reductase (modified from Becker 
and Lowe, 2003). 
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CHAPTER II          WHOLE CELL BIOSYNTHESIS OF A FUNCTIONAL 
OLIGOSACCHARIDE, 2’-FUCOSYLLACTOSE, USING 
ENGINEERED ESCHERICHIA COLI 
 
 
 
 
 
The content of this chapter has been accepted for publication by Microbial Cell Factories. I am 
the second author of the paper. Dr. Won-Heong Lee is the first author and designed the 
experiments. Josh Quarterman, Jung-Hyun Jo, Nam Soo Han, Michael J. Miller, Yong-Su Jin, 
and Jin-Ho Seo were co-authors. I performed the fermentation experiments of E. coli with the 
help from Dr. Won-Heong Lee. Dr. Yong-Su Jin was the director of the research. 
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2.1 Introduction 
Human milk oligosaccharides (HMOs) are known to be the most relevant factor for the 
development of intestinal microbiota in breast-fed infants (Kunz and Rudloff, 2006). Also, 
HMOs have been reported to play important roles in preventing adhesion of pathogens and 
toxins to epithelial surfaces (Bode, 2006). Fucosyloligosaccharides, such as 2’-fucosyllactose, 
lacto-N-fucopentaose and lacto-N-difucohexaose, are common HMOs. Fucosylated 
oligosaccharides act as growth stimulating factors for select Bifidobacteria and soluble analogs 
of receptors for pathogenic bacteria, thereby protecting infants against infection from enteric 
pathogens and binding of toxins (Morrow et al., 2004; Newburg et al., 2004). Specifically, α-1,2-
linked fucosylated oligosaccharides are reported to exhibit protective activity against several 
pathogens including Campylobacter jejuni (Chaturvedi et al., 2001; Morrow et al., 2004), 
Salmonella enteric serotype Typhimurium (Chessa et al., 2009), Enterotoxigenic E. coli 
(Newburg et al., 1990), Helicobacter pylori (Maqalhães and Reis, 2010), and noroviruses 
(Newburg et al., 2005). Among them, 2’-fucosyllactose (2-FL) is the most abundant 
fucosyloligosaccharide in human milk and accounts for more than 30% of total HMOs 
(Chaturvedi et al., 2001; Morrow et al., 2004). Low levels of 2-FL in the milk of sore mothers 
have been reported to be associated with a higher rate of diarrhea in breast-fed infants (Morrow 
et al., 2004). Hence, 2-FL is a promising oligosaccharide for nutraceutical and pharmaceutical 
purposes.  
2-FL can be synthesized through the enzymatic fucosylation of lactose by α-1,2- 
fucosyltransferase (FucT2), which requires guanosine 5’-diphosphate (GDP)-L-fucose as a donor 
of L-fucose (Albermann et al., 2001). Escherichia coli is known to be able to synthesize GDP-L-
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fucose since GDP-L-fucose is used for biosynthesis of colanic acid, one of the main components 
of the cell wall (Stevenson et al., 1996). Therefore, 2-FL can be produced via engineering of the 
GDP-L-fucose biosynthetic pathway and overexpression of the fucosyltransferase gene in 
metabolically engineered E. coli. Fig. 2.1 shows the metabolic pathway for biosynthesis of GDP-
L-fucose and 2-FL in recombinant E. coli.  
Previously, biosynthesis of fucosyloligosaccharides using a recombinant microorganism 
and fucosyltransferase has been reported. The enzymatic synthesis of 2-FL was examined by 
using purified FucT2, GDP-L-fucose and lactose (Albermann et al., 2001), however, the high 
cost of GDP-L-fucose and FucT2 purification may be a limiting factor for large-scale production 
of fucosyloligosaccharides. Production of several fucose-containing lacto-oligosaccharides in 
recombinant E. coli was also reported through simultaneous overexpression of fucosyltransferase 
and the regulatory protein for colanic acid biosynthesis (Drouillard et al., 2006; Dumon et al., 
2001), which suggested that whole cell synthesis of fucosyloligosaccharides through direct 
amplification of the GDP-L-fucose biosynthesis might be feasible.   
To construct an efficient 2-FL production system by metabolic engineering, an 
understanding and detailed analysis of a cellular metabolic network involved in the 2-FL 
biosynthesis is important. Elementary flux mode (EFM) analysis has emerged as a powerful tool 
for metabolic pathway analysis. EFM analysis is a useful mathematical tool for defining and 
describing all metabolic routes that are both stoichiometrically and thermodynamically feasible 
for a group of enzymes. The EFM analysis can decompose a complex metabolic network of 
many highly interconnected reactions into uniquely organized pathways that support steady state 
of metabolism. EFM analysis can provide identification of all genetically independent pathways, 
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determination of the most efficient physiological state of a cell, and analysis of metabolic 
network properties such as robustness and regulation (Pfeiffer et al., 1999; Schuster et al., 2000; 
Trinh et al., 2009). Hence, it can be a useful tool for understanding dynamics of cellular 
metabolism and rational design of the host strain’s metabolism for 2-FL production.  
We have previously developed a recombinant E. coli system for efficient production of 
GDP-L-fucose by metabolic engineering. An enhancement of GDP-L-fucose production was 
achieved by modulation of several factors for biosynthesis of GDP-L-fucose such as 
amplification of GDP-D-mannose biosynthesis, regeneration of NADPH, and manipulation of 
the guanosine nucleotides biosynthetic pathway (Lee et al., 2009, 2011, 2012b).  
In the present study, the GDP-L-fucose production system was applied for efficient 
production of 2-FL by introduction of the FucT2 gene from Helicobacter pylori into the 
recombinant E. coli able to overproduce GDP-L-fucose. Whole cell biosynthesis of 2-FL from 
lactose was assessed in a series of batch fermentations for recombinant E. coli overexpressing 
the necessary genes for GDP-L-fucose production and the FucT2. An EFM analysis for 2-FL 
production in the recombinant E. coli was used to compare and evaluate experimental results.  
 
2.2 Materials and methods 
 
2.2.1 Strains and plasmids 
E. coli TOP10 [F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG] was used for genetic 
manipulation. E. coli BL21star(DE3) [F−, ompT, hsdSB(rB
−mB
−), gal, dcm rne131 (DE3)] 
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(Invitrogen, Carlsbad, CA, USA) and JM109(DE3) [endA1 glnV44 thi-1 relA1 gyrA96 recA1 
mcrB+ Δ(lac-proAB) e14- [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) (DE3)] (NEB, 
Ipswich, MA, USA) were used for production of GDP-L-fucose and 2-FL. Plasmid pmBCGW 
containing the polycistronic gmd-wcaG gene cluster and manB-manC gene cluster was 
previously constructed using plasmid pETDuet-1 (Lee et al., 2009). The gene encoding FucT2 
was obtained by the polymerase chain reactions (PCR) using the genomic DNA of the 
Helicobacter pylori 26695 strain (ATCC 700392) as template (Wang et al., 1999). Two PCR 
primers of fucT2_F and fucT2_R were used for the amplification of the fucT2 gene. After 
digestion of PCR fragments of the fucT2 gene and pCOLADuet-1 (Merck Biosciences, 
Darmstadt, Germany) with NcoI and SacI, the DNA fragments were ligated to construct plasmid 
pHfucT2. Plasmids and primers used in this work are listed in Table 2.1. The constructed 
plasmid was confirmed by DNA sequencing. The conditions for PCR reaction, DNA 
manipulation, and bacterial transformation followed the descriptions in the previous study (Byun 
et al., 2007). 
 
2.2.2 Batch fermentation 
Batch fermentation was carried out in a 250 mL flask containing 50 mL of Lysogeny 
Broth (LB) medium at 25°C and pH 6.8. Agitation speed was maintained at 250 rpm. When dry 
cell mass reached 0.3 g/L, 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added to 
the culture broth. After 3 h of additional cultivation, 2.6 g/L (or 14.5 g/L) lactose was added for 
2-FL production.  
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2.2.3 Analytical methods 
Cell concentration was measured by optical density (OD) at 600 nm using a 
spectrophotometer (Biomate 5, Thermo, NY, USA). Overexpression of FucT2 inside the cell was 
analyzed by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE, 12% 
polyacrylamide). After 3 h of 0.1 mM IPTG induction, cells were collected and the concentration 
was adjusted to around 7.2 g/L. They were resuspended in 50 mM potassium phosphate buffer 
(pH 7.0) and disrupted by an ultrasonic processor. After centrifugation at 15,000×g for 20 min, 
the supernatant (soluble fraction) and debris (insoluble fraction) were separated. Ten microliters 
of the soluble protein fraction (approximately 0.04 mg) and the same volume of the total and 
insoluble protein fractions were subjected to SDS-PAGE. Gels were stained with Coomassie 
brilliant blue solution and images were analyzed using a densitometer. 
Concentrations of lactose, 2-FL, and acetate in batch fermentations were determined by 
using a high performance liquid chromatography (HPLC) system (Agilent Technologies 1200 
Series) equipped with a Rezex ROA Organic Acid H+ column (Phenomenex, Torrance, CA, 
USA) and a refractive index (RI) detector (Agilent, Palo Alto, CA, USA). The column was 
eluted with 0.01 N H2SO4 at a flow rate of 0.6 mL/min at 50°C.  
In order to confirm 2-FL biosynthesis, culture broth at the end of the batch fermentation 
was collected and analyzed using a liquid chromatography/mass spectrometry (LC/MS) system. 
The LC (Agilent Technologies 1100 Series) was equipped with an Agilent Zorbax Eclipse ZDB-
C8 (4.6x150 mm, 5 micron) column and an Agilent LC/MSD Trap XCT Plus detector. The 
column was eluted at a flow rate of 0.4 mL/min by the following gradient program: 95% (v/v) 
eluent A (15 mM ammonium acetate) and 5% eluent B (acetonitrile) for 1 min; 5% to 95% 
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eluent B over 6 min; 95% eluent B over 10 min. The scan range for MS was 70 - 600 mass-to-
charge ratio (m/z). 
 
2.2.4 Construction of metabolic network model for E. coli producing 2-FL from lactose 
A metabolic network model was constructed for 2-FL producing E. coli that grows on 
lactose. The E. coli network was based on a model that was introduced by Stelling et al. (2002) 
to examine the relationship between structure and function in metabolic networks. Furthermore, 
the model has been used for calculating elementary flux modes in previous reports (Klamt et al., 
2005; Urbanczik and Wagner, 2005). The metabolic network was composed of 108 reactions, 
which were involved in carbon central metabolism, amino acid synthesis, fatty acid synthesis, 
and biomass production. The catabolic part of the model included substrate uptake reactions, 
glycolysis, pentose phosphate pathway, TCA cycle, and excretion of by-products (e.g. acetate, 
formate, lactate, and ethanol). Previous networks were extended to include the anaplerotic 
reactions (e.g. malic enzyme and pyruvate oxidase) in addition to parallel pathways for initial 
acetate metabolism. The anabolic part of the model covers the conversion of precursors into 
building blocks like macromolecules and biomass. The core E. coli model from Stelling et al. 
(2002) was modified in this research to account for lactose consumption and synthesis of 2-FL. 
Among the reactions added for 2-FL synthesis, some minor adjustments were made to simplify 
the model. Lactose was assumed to break down to 2 moles of glucose because galactose can be 
easily converted into glucose-6-phosphate. ATP was used in place of GTP for energy transfer. 
As for the mass balance, it should be noted that ADP is formed whenever ATP is consumed for 
all the metabolic reactions in the network. The mass balance equation on ATP is therefore the 
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negative of the mass balance on ADP and thus the two equations are linearly dependent. 
Therefore, ADP can be excluded from the model in order to simplify the subsequent EFM 
calculation. The same is true for other cofactor pairs like NADP/NADPH and NAD/NADH. The 
EFM pathways in the model were estimated using METATOOL 5.1 (Pfeiffer et al., 1999; Trinh 
et al., 2009) with Matlab.  
 
2.3 Results 
 
2.3.1 Expression of α-1,2-fucosyltransferase (FucT2) in recombinant E. coli 
The expression pattern of FucT2 was investigated during a batch fermentation of 
recombinant E. coli harboring plasmid pHfucT2. In order to maximize the expression of the 
soluble form of FucT2 in the recombinant E. coli, 0.1 mM of IPTG was used. As shown in Fig. 
2.2, a 33 kDa protein (consistent with FucT2 (Wang et al., 1999)) was found in both soluble and 
insoluble fraction. While a significant amount of FucT2 was expressed in inclusion bodies, 
biosynthesis of 2-FL was expected because a soluble form of FucT2 was available as well. 
 
2.3.2 Batch fermentations 
From the preliminary experiments (whole cell bioconversion of 2 g/L lactose with E. coli 
BL21star(DE3) strain), we concluded that the E. coli BL21star(DE3) strain is not beneficial for 
2-FL production because it consumed lactose for growth and maintenance instead of converting 
to 2-FL (data not shown). Some E. coli strains, such as DH5α and JM series, are known to be 
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unable to assimilate lactose or utilize lactose extremely inefficiently due to partial deletion of the 
lacZ gene, which codes for β-galactosidase. As such, these E. coli strains might be useful for     
2-FL production. Hence, E. coli JM109(DE3) enabling overexpressing proteins under the control 
of T7 promoter was chosen as an alternative host stain for 2-FL production. 
2-FL production for BL21star(DE3) and JM109(DE3) was compared under batch 
fermentation conditions. In order to allow sufficient production of both GDP-L-fucose 
biosynthetic enzymes and FucT2 inside the cells, the cells were cultivated for 3 hours after 0.1 
mM IPTG induction. Then, 2.6 g/L of lactose was added to initiate 2-FL production without 
addition of additional sugar because GDP-L-fucose can be produced from LB media (Lee et al., 
2009, 2011). During the fermentations, extracellular 2-FL production (in the medium) was 
monitored by HPLC analysis. As a result, a small amount of 2-FL (10 mg/L) was produced in the 
batch fermentation of recombinant E. coli BL21star(DE3). Meanwhile, much higher amount of 
2-FL was produced in the batch fermentation of recombinant E. coli JM109(DE3). About 140 
mg/L of 2-FL was produced from 2.6 g/L of lactose while 0.4 g/L of lactose remained unused at 
the end of the fermentation (data not shown). These results suggest that the lactose concentration 
should be controlled at more than 0.5 g/L to maintain 2-FL production. Consequently, a yield of 
60 mg 2-FL/g lactose was obtained from the batch fermentation of E. coli JM109(DE3) when 2.6 
g/L of lactose was used. In order to obtain a higher amount of 2-FL, a batch fermentation with a 
higher concentration of lactose was carried out. Fig. 2.3 shows the profiles of lactose 
consumption and 2-FL production in the batch fermentation of recombinant E. coli JM109(DE3) 
with 14.5 g/L lactose. The cells consumed lactose slowly but produced 2-FL constantly for 96 h. 
After 96 h of fermentation, the 2-FL concentration did not increase any further and lactose 
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consumption stopped. As a result, a maximum 2-FL concentration of 1.23 g/L was obtained, 
which corresponded to an eight-fold (1.23 g/L vs. 150 mg/L) increase as compared with the 
previous fermentation with 2.6 g/L lactose. 2-FL yield increased to 90 mg 2-FL/g lactose when 
14.5 g/L of lactose was used. This improvement might be caused from increased lactose 
availability inside the cell. The results of the batch fermentations are summarized in Table 2.2. 
 
2.3.3 Confirmation of 2-FL biosynthesis by recombinant E. coli overexpressing GDP-L-
fucose biosynthetic enzymes and FucT2 
LC/MS analysis was performed to confirm the biosynthesis of 2-FL in the recombinant E. 
coli JM109(DE3) strain overexpressing ManB, ManC, Gmd, WcaG, and FucT2. HPLC data 
showed that a compound with the identical retention time to the 2-FL standard compound (Fig. 
2.4A) was detected in the culture broth (Fig. 2.4B). MS scanning data (the compound with the 
retention time = 6.6 min) showed ion fragment of m/z 487.1, which is compatible with that of the 
2-FL standard (Fig. 2.4C). 
 
2.3.4 Evaluation of 2-FL yield using EFM analysis for 2-FL producing E. coli from 
lactose 
In order to evaluate the efficiency of 2-FL production from lactose using the recombinant 
E. coli JM109(DE3) strain, elementary flux mode (EFM) analysis was employed to estimate a 
maximum theoretical yield of 2-FL from lactose. Fig. 2.5 shows the prediction of theoretical     
2-FL yield versus biomass yield for E. coli growing on lactose. Our experimental result from a 
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batch fermentation of 14.5 g/L of lactose resulted in a biomass yield of 0.1 g biomass/g lactose. 
This suggests that 2-FL production from lactose by the engineered E. coli reached 20% of the 
maximum 2-FL production capacity.  
 
2.4 Discussion 
In human milk, α-1,2-fucosylated oligosaccharides such as 2-FL, are known to have 
protective activity against pathogenic bacteria and their toxins (Chaturvedi et al., 2001; Morrow 
et al., 2004; Newburg et al., 2005). Hence, the availability of large amounts of α-1,2-fucosylated 
oligosaccharides would be useful in ready-to-use materials, drugs for fundamental investigations 
or therapeutic purposes. As biosynthesis of GDP-L-fucose, a key compound for biosynthesis of 
α-1,2-fucosylated oligosaccharides, requires a number of enzymes and cofactors such as NADPH 
and GTP, a whole-cell conversion approach might be more realistic for industrial production 
than other chemical or enzymatic approaches (Ruffing and Chen, 2006). 
In previous studies, improvements of GDP-L-fucose production in recombinant E. coli 
were attempted by manipulating the pathways enabling GDP-L-fucose biosynthesis from glucose 
(Lee et al., 2009, 2011, 2012b). This study was undertaken to upgrade the GDP-L-fucose 
production system for 2-FL production through additional overexpression of FucT2. To this end, 
the fucT2 gene from H. pylori was cloned and overexpressed in the E. coli BL21star(DE3) strain. 
While an insoluble form of FucT2 was a major expression form, an active FucT2 was also 
observed in the recombinant E. coli as shown in Fig. 2.2. With the aid of FucT2 overexpression, 
recombinant E. coli BL21star(DE3) could produce 2-FL in the batch fermentation with 2.6 g/L 
lactose. However, 2-FL yield was fairly low (4 mg 2-FL/g lactose). E. coli BL21star(DE3) 
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seemed to assimilate lactose instead of converting to 2-FL. Most of the initially added lactose 
was consumed within 12 h of fermentation with a marginal growth during the fermentation (data 
not shown). These results suggested that E. coli BL21star(DE3) is not appropriate for 2-FL 
production.  
Previously, several attempts for production of fucosylated (or sialylated) oligosaccharides 
from lactose have been made using the derivative of E. coli JM107 and JM109 since these strains 
are unable to produce an active β-galactosidase due to the insertion of the M15 single strand 
DNA into the lacZ gene (Dumon et al., 2001, 2004; Drouillard et al., 2006; Fierfort and Samain, 
2008). In these cases, glucose (or glycerol) was used as another carbon source for GDP-L-fucose 
production (or CMP-N-acetylneuraminic acid). These nucleotide sugars are subsequently used 
for fucosylation (or sialylation). According to the previous reports, E. coli JM109(DE3) was 
chosen as an alternative host strain for 2-FL production. As expected, the use of E. coli 
JM109(DE3) allowed production of  a considerable amount of 2-FL in the batch fermentation, 
corresponding to a 15-fold increase in 2-FL concentration compared with the value obtained in 
BL21star(DE3) strain. However, a theoretical yield of 2-FL from lactose was predicted to be 1.4 
g 2-FL/g lactose when cells cannot utilize lactose for growth. Meanwhile, our experimental yield 
of 2-FL was only about 0.1 g 2-FL/g lactose. This result indicates that more than 90% of lactose 
consumed was used for other purposes such as biomass production and endogenous metabolism. 
Slow consumption of lactose was also observed in the batch fermentation with mixed sugars (2 
g/L of lactose and 5 g/L of mannose), where we expected that lactose could be mainly used for    
2-FL production as mannose might be used for cell growth. Although an enhancement of 2-FL 
yield (0.13 g 2-FL/g lactose) was obtained, most of the consumed lactose was not used for 2-FL 
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production (data not shown). It is probable that incompletely inactivated β-galactosidase or 
cryptic β-galactosidase inside the cell might cause the reduction of 2-FL yield from lactose. 
Insertion of λ(DE3) into the genome might cause the slow assimilation of lactose, which was 
supported by a previous report that α-complementation of LacZ was observed with the insertion 
of the DE3 cassette into the genomic DNA of E. coli JM101 (Dumon et al., 2004).  
Since slow consumption of lactose and production of biomass were observed in the batch 
fermentation with 2.6 g/L lactose, another batch fermentation with a high concentration of 
lactose (14.5 g/L) was conducted in order to obtain a higher amount of 2-FL. Generally, E. coli is 
known to produce acetate when growing on an excessive sugar even under aerobic conditions. 
However, JM109(DE3) strain showed no acetate production even when excessive amounts (14.5 
g/L) of lactose were added as displayed in Fig. 2.3. It is generally known that acetate formation 
is accelerated when the metabolic fluxes to pyruvate exceed the capacity of the respiratory 
metabolism (Lee, 1996; Zhao et al., 2004). Slow consumption of lactose might not lead to 
acetate formation, suggesting that the lactose utilization rate by E. coli JM109(DE3) is not fast 
enough to cause acetate formation. This result could be beneficial for designing a 2-FL 
production process such as a fed-batch type operation since acetate formation is known to be one 
of the main problems occurring in fed-batch type operations of E. coli (Lee et al., 2011). 
However, low yield and productivity of 2-FL from lactose will need to be improved for industrial 
applications. The 2-FL production system in this study was verified by comparing the 
experimental 2-FL yield with the theoretical maximum yield estimated by the EFM analysis.     
2-FL yield corresponded to about 20% of the theoretical maximum yield, which suggests further 
modifications via metabolic engineering of a host strain or optimization of fermentation 
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processes should be carried out for improvement of 2-FL yield. Increased FucT2 solubility and 
intracellular lactose availability may be considered as primary approaches for improvement of  
2-FL yield. 
In this study, construction of efficient 2-FL production system was attempted. The fucT2 
gene from H. pylori was introduced into the recombinant E. coli able to overproduce GDP-L-
fucose and biosynthesis of 2-FL was observed in the batch fermentation with lactose. The 2-FL 
production system using the E. coli JM109(DE3) strain showed a low rate of lactose assimilation 
and produced a considerable amount of 2-FL in the simple batch fermentation without acetate 
formation. The experimental 2-FL yield corresponded to 20% of the theoretical maximum yield, 
which indicates that more research should be conducted. Efficient microbial 2-FL production 
may be useful for utilizing 2-FL as a nutraceutical compound for various applications. 
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2.5 Figures and tables  
 
Fig. 2.1 The metabolic pathway for GDP-L-fucose and 2’-fucosyllactose (2-FL) biosynthesis in 
recombinant E. coli. The names of enzymes are abbreviated as follows; ManA, mannose 6-
phosphate isomerase; ManB, phosphomannomutase; ManC, mannose 1-phosphate 
guanylyltransferase; Gmd, GDP-D-mannose-4,6-dehydratase; WcaG, GDP-4-keto-6-
deoxymannose 3,5-epimerase 4-reductase; FucT2, α-1,2-fucosyltransferase. Pi, GDP, and GTP 
denote phosphate, guanosine 5’-diphosphate, and guanosine 5’-triphosphate, respectively. 
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Fig. 2.2 SDS-PAGE analysis of the cell crude extract of recombinant E. coli BL21star(DE3) 
strains harboring pCOLADuet-1 and pHfucT2, respectively. Cells were harvested after 3 h of 0.1 
mM IPTG induction. T, S, and I denote total, soluble and insoluble protein fractions, 
respectively. The arrow indicates the corresponding protein band with the estimated molecular 
weight of FucT2. Lane M indicates size marker. 
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Fig. 2.3 Profile of 2-FL production in the batch fermentation of recombinant E. coli 
JM109(DE3) strains harboring plasmids pmBCGW and pHfucT2. After 3 h of 0.1 mM IPTG 
induction, 14.5 g/L of lactose was added for 2-FL production. Symbols denote as follows; light 
blue circle, dry cell mass; red circle, 2-FL concentration; green circle, lactose concentration; 
purple circle, acetate concentration. Measurement of cell, lactose, acetate, and 2-FL 
concentrations was done by three independent experiments. Symbols in the figure show the 
representative values of the batch fermentations. 
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Fig. 2.4 LC/MS analysis of 2-FL biosynthesis in the batch fermentation of the recombinant E. 
coli JM109(DE3) overexpressing ManB, ManC, Gmd, WcaG, and FucT2. At the end of batch 
fermentation, culture broth was collected for confirmation of extracellular 2-FL production. 
HPLC analysis of 100 mg/L 2-FL standard solution (A), HPLC analysis of culture broth of E. 
coli JM109(DE3) harboring pmBCGW+pHfucT2 (B), and MS analysis of the compound with 
the retention time = 6.6 min in the culture broth of E. coli JM109(DE3) harboring 
pmBCGW+pHfucT2 (C). 
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Fig. 2.5 Calculation of the theoretical maximum yield of 2-FL from lactose. Elementary flux 
mode (EFM) analysis was carried out for 2-FL producing E. coli.
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Table 2.1 Lists of primers and plasmids used in this study 
Name Sequence of PCR primers and description for plasmids Source 
PCR primers   
fucT2_F (NcoI) 5’-ACATGCCATGGCTTTTAAGGTGGTGCAA-3’ H. pylori 26695 
(ATCC 700392) fucT2_R (SacI) 5’-AGTCCGAGCTCTTAAGCGTTATACTTTTGGGA-3’ 
Plasmids   
pETDuet-1 two T7 promoters with two MCS, pBR322 replicon (copy number ~40), Ampr Merck Biosciences 
pCOLADuet-1 two T7 promoters with two MCS, ColA replicon (copy number 10~12), Kanr Merck Biosciences 
pmBCGW derived from pETDuet-1, PT7-manB-manC (NcoI/SacI)-PT7-gmd-wcaG (NdeI/XhoI)-TT7, Ampr Lee et al., 2009 
pHfucT2 derived from pCOLADuet-1, PT7- fucT2 (NcoI/SacI)-PT7-MCS2-TT7, Kanr this study 
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Table 2.2 Summary of batch fermentations of E. coli strains producing 2-FL from lactose 
Strains Plasmids 
Initial lactose 
concentration (g/L) 
Maximum 
dry cell mass (g/L) 
Maximum 2-FL 
concentration (g/L) 
Yield 
(g 2-FL/g lactose) 
BL21star(DE3) pmBCGW + pHfucT2 2.56±0.04 1.84±0.05 0.01±0.001 0.005±0.001 
JM109(DE3) pmBCGW + pHfucT2 2.55±0.02 1.17±0.05 0.15±0.014 0.06±0.005 
  14.54±0.67 1.70±0.28 1.23±0.011 0.09±0.004 
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CHAPTER III          OPTIMIZATION OF 2’-FUCOSYLLACTOSE PRODUCTION 
CONDITIONS IN ENGINEERED ESCHERICHIA COLI 
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3.1 Introduction 
In the past decade, 2-FL, a human milk oligosaccharide, has been perceived as a 
functional oligosaccharide owing to its interesting gut health boosting attributes (Bode, 2006, 
2012). Possessing health benefits, 2-FL demand has been increasing in order to investigate its 
biological functions and physicochemical properties. Possible applications include 
supplementation of 2-FL in infant formula and food products. 
 Nevertheless, the access to 2-FL is limited due to its high cost. Currently, 2-FL is 
synthesized by a chemical process. Extraction of 2-FL from human breast milk is impractical. 
These limitations hinder the extension of 2-FL research (Han et al., 2012). Alternatively, the 
enzymatic and biotechnological approaches to synthesize 2-FL have been developed which are 
more simple and more cost-effective than existing 2-FL production methods (Albermann et al., 
2001; Baumgartner et al., 2013; Drouillard et al., 2006; Lee et al., 2012a; Wada et al., 2008). The 
prerequisites to biologically synthesize 2-FL are guanosine-5’-diphosphate (GDP)-L-fucose (a 
donor of L-fucose), D-lactose, and α-1,2-fucosyltransferase (FucT2) enzyme which catalyzes the 
transfer reaction of L-fucose to the acceptor, D-lactose (Albermann et al., 2001). GDP-L-fucose 
may be obtained via in vivo metabolic conversions from GDP-D-mannose (De novo pathway) 
(Bulter and Elling, 1999) or from L-fucose (Salvage pathway) (Coffey et al., 1964). L-fucose 
may be acquired extracellularly or intracellularly through catabolism of fucosylated glycans in 
lysosome (Becker and Lowe, 2003). The de novo pathway involves two enzymatic reactions of 
GDP-D-mannose-4, 6-dehydratase (GMD) and GDP-4-keto-6-deoxymannose-3, 5-epimerase-4-
reductase (WcaG or FX) responsible for converting GDP-D-mannose to GDP-L-fucose (Byun et 
al., 2007; Tonetti et al., 1996). In the salvage pathway, an external L-fucose is transported into 
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the cytosol by L-fucose permease (FucP) while L-fucose generated in the lysosome is liberated 
into the cytosol by facilitated diffusion (Baumgartner et al., 2013; Jonas et al., 1990). Two 
enzymatic conversion steps are required to convert L-fucose to GDP-L-fucose including L-
fucose kinase (FUK) and GDP-fucose pyrophosphorylase (GFPP) (Becker and Lowe, 2003). 
Alternately, a one-step conversion of L-fucose to GDP-L-fucose is possible by expression of the 
bifunctional enzyme, L-fucose kinase/L-fucose-1-phosphate guanylyltransferase (Fkp), from 
Bacteroides fragilis (Baumgartner et al., 2013).  
 The enzymatic synthesis of 2-FL was first reported from the de novo fucosylation of 
lactose encouraged by the FucT2 enzyme with a 65% yield of 2-FL after purification by anion-
exchange chromatography and gel filtration (Albermann et al., 2001). GDP-L-fucose is also 
known as a precursor for the biosynthesis of colanic acid, an exopolysaccharide found in 
Enterobacteriaceae (Stevenson et al., 1996). Further attempt to produce 2-FL was then focused 
on eliminating the competing pathways and increasing the metabolic flux toward the pathway of 
the desirable product (Drouillard et al., 2006). To reserve GDP-L-fucose for 2-FL production, 
the enzyme which catalyzes the synthesis of colanic acid from GDP-L-fucose, colanic acid 
biosynthesis UDP-glucose lipid carrier transferase (WcaJ), was disrupted. β-galactosidase (LacZ) 
was also deactivated to secure intact lactose for 2-FL conversion by preventing the metabolism 
of lactose to biomass. Additionally, the positive regulator protein of the colanic acid operon, 
RcsA, was overexpressed to enhance the flux toward GDP-L-fucose production. By utilizing the 
de novo derived GDP-L-fucose and supplementing 15 g/L of lactose to the growth medium, the 
recombinant E. coli was able to produce 11 g/L of 2-FL extracellularly. More recently, the de 
novo and salvage approaches for GDP-L-fucose formation were coupled to intensify the 
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intracellular availability of GDP-L-fucose (Baumgartner et al., 2013). The optimized 
recombinant E. coli strain, which has the de novo GDP-L-fucose synthesizing genes, two copies 
of fucosyltransferase gene, and the fkp gene integrated into the chromosome, produced 2-FL up 
to 20.28 g/L in the glycerol-limited fed-batch fermentation. Furthermore, 2-FL can be 
synthesized enzymatically using the glycosynthase technology (Wada et al., 2008). The α-1,2 
linkage connecting L-fucose and D-galactose in the 2-FL structure can be created with the 
activity of 1,2-α-L-fucosynthase. The 1,2-α-L-fucosynthase can be generated from the inverting 
1,2-α-L-fucosidase isolated from Bifidobacterium bifidum via D766G mutation. Through the 
enzymatic reaction comprising 10 mM β-L-fucosyl fluoride triacetate (L-fucose donor), 30 mM 
lactose (acceptor), and the 1,2-α-L-fucosynthase enzyme, approximately 650 µM of 2-FL can be 
synthesized in 2 hours at 30°C.  
 Previously we have established an engineered E. coli capable of producing 2-FL by 
overexpressing the de novo GDP-L-fucose synthesizing enzymes (manB, manC, gmd, and wcaG) 
from E. coli and the fucT2 enzyme from Helicobacter pylori strain 26695 (Lee et al., 2012a). 
However, the variation of fermentation conditions was found to contribute greatly to the yield of 
the produced 2-FL. To consistently secure an efficient 2-FL production system, fermentation 
parameters such as culture growth temperature, concentration of isopropyl-β-D-
thiogalactopyranoside (IPTG), time of the IPTG induction, and availability of lactose should be 
considered and optimized. In the present study, fermentation conditions used in the whole-cell 
biosynthesis of 2-FL by the engineered E. coli were investigated to determine the most 
appropriate environments promoting the efficient synthesis of 2-FL. 
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3.2 Materials and methods 
 
3.2.1 Strain and plasmids 
E. coli JM109(DE3) [endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-proAB) 
e14- [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) (DE3)] (NEB, Ipswich, MA, USA) 
was used for production of GDP-L-fucose and 2-FL. Plasmid pmBCGW containing the 
polycistronic gmd-wcaG gene cluster and manB-manC gene cluster was previously constructed 
using plasmid pETDuet-1 (Lee et al., 2009). Plasmid pHfucT2 harboring the α1,2 fucT2 gene 
from H. pylori strain 26695 was previously constructed using plasmid pCOLADuet-1 (Lee et al., 
2012a). Plasmids used in this work are listed in Table 3.1.  
 
3.2.2 Culture preparation 
The engineered E. coli JM109(DE3) transformed with plasmids pmBCGW and pHfucT2 
was grown in Lysogeny Broth (LB; sodium chloride 10 g/L, yeast extract 5 g/L, tryptone 10 g/L) 
supplemented with antibiotics (ampicillin 100 µg/mL and kanamycin 50 µg/mL). Antibiotics 
were administered to permit only the growth of E. coli harboring the above two plasmids 
necessary for 2-FL synthesis. The culture tube was routinely incubated at either 30°C for 16 h or 
37°C for 12 h before starting the main fermentation of 2-FL (pre-culture).   
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3.2.3 Batch and fed-batch fermentation 
The cell pellet of the late-exponentially grown pre-culture was used to inoculate the main 
fermentation. Typically, the main fermentation was performed using a 250 mL shake flask 
containing 50 mL working volume of LB medium, antibiotics, IPTG, and lactose. The culture 
flask was placed at either 25, 30, or 37°C in 300 rpm shaking incubators (Thermo Scientific, 
MA, USA). Small amounts of culture were sampled and analyzed every 24 hours to monitor cell 
growth and metabolite changes during the fermentation. All fermentation conditions were 
experimented in triplicates. 
Fed-batch fermentation was also carried out in a 250 mL shake flask containing 50 mL 
working volume of the same aforementioned components as the batch fermentation. The culture 
flask was incubated at 25°C. Agitation speed was maintained at 300 rpm. 0.1 mM IPTG and 15 
g/L lactose were added at the beginning of fermentation. As the initial/previous lactose depleted, 
lactose of roughly 15 g/L was replenished in the culture medium for three more times to allow a 
continuous accumulation of 2-FL.  
 
3.2.4 IPTG induction experiment  
IPTG is a structural mimic of lactose serving as a permanent inducer for the expressions 
of GDP-L-fucose biosynthetic genes and fucT2 gene. Two concentrations of IPTG (0.1 and 0.5 
mM) and two different times of induction (at the beginning simultaneously with cell inoculation 
and at the dry cell mass (DCM) level of 0.216 g/L) were tested in the batch fermentation.    
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3.2.5 Lactose concentration experiment 
Different concentrations of lactose were studied to see how they affect 2-FL production. 
Lactose concentrations consisting of 10, 15, 20, and 40 g/L were tested in the batch fermentation.  
 
3.2.6 Analytical methods 
Cell concentration was measured by optical density (OD) at 600 nm using a 
spectrophotometer (Biomate 5, Thermo, NY, USA). Dry cell mass was calculated using an 
estimate of 0.36 gram cells per OD value of 1. Concentrations of lactose, 2-FL, and acetate in 
batch fermentations were determined using a high performance liquid chromatography (HPLC) 
system (Agilent Technologies 1200 Series) equipped with a Rezex ROA Organic Acid H+ 
column (Phenomenex, Torrance, CA, USA) and a refractive index (RI) detector (Agilent, Palo 
Alto, CA, USA). The column was eluted with 0.005 N H2SO4 at a flow rate of 0.6 mL/min at 
50°C. 
 
3.3 Results 
 
3.3.1 Effect of pre-culture and main fermentation temperatures on 2-FL production 
 The effect of temperature used in cultivating the engineered E. coli during pre-culture and 
main fermentation on the ability of the cells to produce 2-FL was investigated. Pre-culture is 
defined as the period of time from picking a single colony of cells to getting an exponentially-
grown culture. The purpose of pre-culture is to prepare a sufficient inoculum for starting a main 
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fermentation. Main fermentation is usually initiated by resuspending the cell pellet from pre-
culture with a complete growth medium including (a) sugar substrate(s) and other fermentation 
necessities such as an inducer for protein expression and (an) antibiotic(s) for selection of the 
cells containing the expression plasmids.  
 Six combinations of two pre-culture temperatures (30 and 37ºC) and three main 
fermentation temperatures (25, 30, and 37ºC) were attempted and compared to determine the 
conditions that have the positive impact on 2-FL synthesis. As illustrated in Fig. 3.1 and 3.2, the 
difference of pre-culture temperatures did not seem to significantly influence the growth 
(represented in dry cell mass) of the engineered E. coli in the main culture regardless of the main 
fermentation temperature. The overall trends portrayed a slightly better growth of the cells 
experienced a higher pre-culture temperature (37ºC) than the cells from a lower pre-culture 
temperature (30ºC). Apparently, the main fermentation temperature plays an important role in 
cell growth. The cells grown at 25 and 30ºC in main culture generally reached a higher cell mass 
(above 3 g/L) than the ones grown at 37ºC no matter what temperature was used in the pre-
culture. 
In terms of lactose consumption, only the cells subjected to 30ºC pre-culture and later 
grown at 25ºC in main culture consumed lactose efficiently and were able to finish the provided 
lactose of about 15 g/L within 96 hours of fermentation. The cells grown at 30ºC pre-culture-
30ºC main culture and 37ºC pre-culture-25 or 30ºC main culture also assimilated lactose 
relatively well up to 72 hours, but then slowed down the consumption and left a few grams of 
lactose unused at the end of the fermentation. Nevertheless, the cells exposed to 37ºC main 
 41 
 
fermentation temperature, irrespective of pre-culture temperature, consumed lactose quickly at 
the beginning, but ceased to assimilate more lactose just after 24 hours of fermentation.   
Another metabolite of interest, acetate is an unwanted by-product commonly excreted by 
E. coli in aerobic fermentation (Farmer and Liao, 1997). A high acetate accumulation in the 
medium (~over 2 g/L) adversely affects cell growth and the yield of recombinant protein 
production, thereby decreasing the amount of a desirable product (Landwall and Holme, 1977; 
Mori et al., 1979; Reiling et al., 1985). The engineered E. coli cultivated at 25ºC main 
fermentation, regardless of pre-culture temperature, produced almost no acetate throughout the 
fermentation. The amount of acetate generated seemed to positively correlate with the higher 
temperature. The cells grown at 30ºC main fermentation preceded by any pre-culture temperature 
secreted over 2 g/L of acetate. As the main culture temperature rose to 37ºC, an acetate buildup 
of over 3 g/L was observed.  
With respect to 2-FL synthesis, pre-culture at 30ºC and main fermentation at 25ºC were 
the best conditions yielding 0.92 g/L of 2-FL. The cells from 37ºC pre-culture-25ºC main culture 
performed the second best with 0.82 g/L of 2-FL. While the culture grown at 30ºC in main 
fermentation, irrespective of pre-culture condition, produced about 0.4-0.5 g/L of 2-FL, the 
culture from 37ºC main fermentation barely produced any 2-FL.   
In summary, the temperature combination of 30ºC pre-culture-25ºC main culture 
manifested the most excellent condition for 2-FL production because the engineered E. coli gave 
the highest titer of 2-FL, had better cell growth, completely fermented lactose, and accumulated 
the least amount of acetate. 
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3.3.2 Effect of IPTG induction conditions on 2-FL production  
 The effect of IPTG induction on 2-FL production was studied in two aspects comprising 
IPTG working concentration and time of IPTG addition. IPTG, a non-metabolisable inducer, is 
indispensable when using the plasmid with T7 promoter in order to get the expression of your 
target gene. It functions to remove the attachment of a lac repressor (LacI) from the lac operator 
DNA sequence by causing the conformational change in the structure of LacI protein. Without 
the repressor, the T7 RNA polymerase protein will be able to express and bind to the T7 
promoter sequence located upstream of the gene triggering transcription of the target gene (Bell 
and Lewis, 2000; Daber et al., 2007).  
 Two concentrations (0.1 and 0.5 mM) and two times of induction (at the beginning of 
fermentation and at Dry Cell Mass (DCM) of 0.216 g/L) of IPTG were examined. According to 
the best condition determined from the temperature effect experiment, 30°C pre-culture and 
25°C main culture were used to grow the cells in the IPTG experiments.  
Regarding cell growth, Fig. 3.3 clearly shows that 0.1 mM concentration of IPTG led to 
the better cell growth compared with 0.5 mM concentration. The engineered E. coli rapidly grew 
up to DCM of 4.8 g/L in 0.1 mM IPTG conditions regardless of the time of IPTG addition. The 
second best growth was from the culture with 0.5 mM IPTG supplemented at DCM of 0.216 g/L. 
The cells produced DCM of 4.5 g/L but at a slower rate than the ones induced with 0.1 mM 
IPTG. However, it seemed that the addition of 0.5 mM IPTG at the beginning of fermentation 
negatively affected the cell growth in the early stage of the fermentation though the cells reached 
the same DCM of 4.5 g/L later as the ones supplemented with IPTG at DCM of 0.216 g/L.  
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In terms of lactose assimilation, it was obvious that the engineered E. coli grown in 0.1 
mM IPTG added at the beginning consumed lactose faster than the rest of the tested conditions. 
They finished 18 g/L lactose in about 84 hours. The E. coli with 0.1 and 0.5 mM IPTG added at 
DCM of 0.216 g/L behaved similarly and completed all lactose within 96 hours. Yet, the E. coli 
with 0.5 mM IPTG added at the beginning had trouble to finish lactose and left a little amount of 
lactose unconsumed by the end of the fermentation.  
With regard to 2-FL production, there was no difference in 2-FL synthesizing ability 
between supplementation of 0.1 mM at the beginning of fermentation or at DCM of 0.216 g/L. 
These two conditions gave about 0.72 g/L of 2-FL at the end of the day which is higher than the 
conditions of 0.5 mM IPTG at DCM of 0.216 g/L (0.5 g/L of 2-FL) and 0.5 mM IPTG at the 
beginning (0.2 g/L of 2-FL). 
In regard to acetate, the induction condition of 0.5 mM IPTG at the beginning of 
fermentation solely had a significant quantity of acetate (~1.2 g/L) while a tiny amount of or no 
acetate was detected in all other conditions.   
In summary, 0.1 mM IPTG induction at the beginning of fermentation resulted in the 
most desirable phenotypes of the engineered E. coli (better cell growth, more efficient lactose 
usage, higher 2-FL production, and no acetate formation).  
 
3.3.3 Effect of lactose availability on 2-FL production 
Referring to the previous best conditions from the effects of temperature and IPTG 
experiments, 30°C pre-culture, 25°C main fermentation, and 0.1 mM IPTG addition at the 
beginning of fermentation were consequently employed in all lactose concentration experiments. 
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With regard to cell growth, it seemed that there was no exact relationship between lactose 
concentration and cell growth (Fig. 3.4). The engineered E. coli fed with 40 g/L lactose grew the 
best (up to DCM 5 g/L) among all experimented lactose concentrations. The declining period of 
growth in 10 and 15 g/L conditions was disregarded because the lactose substrate was depleted 
resulting in the gradual cell death.   
In relation to lactose utilization, the speed of lactose completion of the engineered E. coli 
was directly associated with the concentration of lactose. As expected, the cells were able to 
finish lower lactose concentration quicker than higher lactose concentration. 10, 15, and 20 g/L 
were completely consumed within 72, 96, and 120 hours, respectively. Still, 40 g/L condition 
had some remaining lactose in the culture at the end of the experimental time (168 hours).  
In terms of 2-FL production, the engineered E. coli supplemented with 10, 15, 20, and 40 
g/L lactose produced 2-FL similarly of about 1 g/L at 168 hours. Therefore, higher lactose 
concentration does not necessarily mean higher 2-FL production.  
In summary, 10 g/L lactose concentration seemed to be the best option to produce 2-FL 
in a batch fermentation setting considering the amount of 2-FL produced (1 g/L) from the less 
amount of lactose needed (a cheaper process). 
 
3.3.4 Fed-batch fermentation of 2-FL 
To increase the 2-FL titer, the strategy of fed-batch fermentation may be useful since the 
higher availability of lactose in a single batch did not improve 2-FL production as tested in the 
previous section. To perform the fed-batch fermentation, a normal batch fermentation is first 
conducted with a low initial lactose concentration of ~10-15 g/L (Fig. 3.5). Once the initial 
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lactose is almost used up, more lactose is added into the culture. The addition of lactose may be 
repeated continually to maintain cell growth and provide sufficient substrates for 2-FL 
accumulation. Moreover, a higher initial cell density (DCM) of 3.6 was applied to accelerate the 
utilization of lactose and reduce the overall fermentation time. 
In terms of cell growth, the engineered E. coli reached the maximum DCM of 9 g/L at 
120 hours. The addition of more lactose to the culture did not further augment the cell number. 
Yet, the cell population maintained at above DCM of 7 g/L throughout the rest of fermentation. 
In regard to lactose consumption, the rate of lactose utilization slowed down (less steep 
slopes) as the fermentation progressed and more lactose was supplemented. By raising the initial 
cell mass to ~3.6, 15 g/L of lactose was assimilated within 36 hours. However, the speed of 
lactose uptake declined in the second round of lactose. 48 hours were needed to finish about the 
same amount of lactose. By the fourth round of lactose, the cells obviously decelerated their 
lactose consumption and spent almost 90 hours to consume the same lactose 15 g/L. 
Acetate was present during the primary stage of fermentation at low levels (less than 0.5 
g/L) before 72 hours. Nonetheless, acetate vanished after this point and remained undetected 
throughout the rest of fermentation. 
Regarding 2-FL formation, a continuous increase of 2-FL was observed as more lactose 
was provided to the cells. At the end of the fermentation (245 hours), the highest titer of 2-FL of 
4.35 g/L was achieved.     
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3.4 Discussion 
To secure an efficient and stable system of the whole-cell biosynthesis of 2-FL by the 
engineered E. coli, the process components related to fermentation condition and gene 
expression are crucial and should be carefully chosen in order to acquire the strain with the best 
performance. Three aspects associated with 2-FL production were investigated including pre-
culture/main culture temperature, IPTG induction condition, and lactose availability.  
In regard to fermentation temperature, pre-culture temperature (either 30 or 37°C) is not 
really a main contributing factor affecting 2-FL synthesis. The mere LB medium containing 
amino acids and limited carbon sources was employed to support cell growth to less than 2 g/L 
DCM during pre-culture. Hence, the cells in pre-culture underwent a minimal cell metabolism 
and the proteins related to 2-FL production were not yet induced and expressed. Rather, main 
fermentation temperature played an important role in the cells’ ability to make 2-FL. 2-FL titer 
was adversely correlated with the rise of main culture temperature. At 37°C, the cell metabolism 
ran faster. Therefore, lactose was quickly consumed during the first 24 hours creating the strong 
carbon fluxes going down glycolysis and citric acid (TCA) cycle. These strong fluxes had to 
subsequently overflow to acetate production pathway since they overloaded what the glycolysis 
and TCA cycle could handle (Vemuri et al., 2006). Once acetate buildup exceeded 2 g/L, it 
negatively impacted cell growth, sugar uptake, and protein production (Chong et al., 2013). A 
similar situation of fast metabolic fluxes happened with 30°C condition but to a lesser extent. 
The cells grew and fermented lactose relatively well until 72 hours. Still, over 2 g/L of acetate 
was later generated causing the cells unable to use up all lactose during the last period of 
fermentation. On the other hand, a lower culture temperature like 25°C did not ensue such a high 
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speed of metabolism. The carbon fluxes from lactose degradation were at an appropriate level 
and did not inundate the central metabolic pathway. Thus, almost no acetate was produced and 
the cells were able to grow healthily. In respect of 2-FL formation, the lower cell metabolism at 
the low temperature also grants the produced protein ample time to properly fold and become a 
functional/soluble protein (Baneyx and Mujacic, 2004). On the contrary, proteins are produced 
rapidly at the higher cell metabolic rate (high temperature) but they do not have time to 
adequately fold and eventually aggregate to form inclusion bodies (insoluble protein) (Singh et 
al., 2015). 
Concerning IPTG induction, IPTG concentration used to induce the recombinant protein 
production was clearly shown to influence 2-FL production. A higher IPTG concentration of 0.5 
mM turned out unhelpful for 2-FL formation. It is likely that such the high amount of IPTG gave 
the cells a metabolic burden and reduced their growth rates (Kosinski et al., 1992). When they 
were sick, they were not able to produce 2-FL as well. Instead, more carbons were constituted as 
acetate, a by-product. In consideration of time of induction, the time of IPTG addition did not 
alter the amount of 2-FL much when exposing a low IPTG concentration (0.1 mM) to the cells. 
However, at a higher IPTG content (0.5 mM), the induction at the beginning of fermentation 
strongly diminished the cell growth rate. This could be due to the metabolic stress pushing the 
cells to produce lots of protein when they were trying to increase their biomass to get through the 
lag phase. Most researchers recommended the induction of IPTG during the exponential cell 
growth (DCM 0.216-0.288 g/L). At this stage of growth, the chaperones necessary for reversal of 
misfolded proteins are sufficiently expressed (Schlieker et al., 2002). The majority of soluble 
proteins can be retained benefiting the product yield. Nevertheless, we decided to move forward 
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with 0.1 mM IPTG induced at inoculation which generated 2-FL as good as the exponential 
induction condition for the convenience of fermentation experiment.   
Regarding lactose availability, a higher lactose concentration provided to the growth 
medium did not automatically increase 2-FL production. This may be explained by the 
limitations of other factors, for instance, the availability of GDP-L-fucose substrate and the 
efficiency of fucosyltransferase, which overall made the conversion to 2-FL not so effective. We 
determined the low concentration of lactose (10-15 g/L) as an optimum condition for performing 
a batch fermentation of 2-FL since the same amount of 2-FL can be obtained as in the higher 
concentration of lactose and all lactose can be assimilated within a reasonable amount of time. 
The complete utilization of lactose would ease the subsequent purification of 2-FL. 
As a direct supplementation of more lactose was not beneficial for improving a 2-FL 
titer, a periodic supply of lactose was attempted in a fed-batch fermentation. The fed-batch 
experiment was conducted using the best fermentation conditions identified previously. In 
addition, a higher initial cell density (DCM 3.6 g/L) was exploited to accelerate the lactose 
utilization. By supplying a low amount of lactose at a time, the finite lactose availability 
triggered the cells to continue to utilize lactose for converting to both biomass and 2-FL. 
Through this strategy, 2-FL titer can be enhanced as more lactose is consumed.  
In conclusion, production of 2-FL from engineered E. coli JM109(DE3) was greatly 
dependent on the fermentation conditions. After subjecting the engineered E. coli through 
various experiments, the best conditions to produce 2-FL were 30ºC pre-culture-25ºC main 
fermentation temperature and 0.1 mM IPTG induction at the beginning of fermentation. 
Moreover, a low lactose concentration (10-15 g/L) seemed to be the most efficient working 
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concentration for a batch fermentation. A fed-batch fermentation technique was advantageous 
raising the titer of 2-FL to 4.35 g/L (considered over three folds of advancement from the batch 
fermentation). Nevertheless, a thorough optimization of production conditions may need to be 
performed in the future to achieve an even better yield of 2-FL.  
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3.5 Figures and tables 
 
Fig. 3.1 Batch fermentation profiles of recombinant E. coli strain JM109(DE3) harboring 
plasmids pmBCGW and pHfucT2. Effects of pre-culture and main fermentation temperatures on 
2-FL production were studied. The cells were pre-cultured at 30°C. Then, they were grown at 
either 25, 30, or 37°C in main fermentation. During main fermentation, cell growth, lactose 
consumption, acetate production, and 2-FL production were monitored. Symbols denote as 
follows; light blue circle, 25°C; green circle, 30°C; purple circle, 37°C.  
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Fig. 3.2 Batch fermentation profiles of recombinant E. coli strain JM109(DE3) harboring 
plasmids pmBCGW and pHfucT2. Effects of pre-culture and main fermentation temperatures on 
2-FL production were studied. The cells were pre-cultured at 37°C. Then, they were grown at 
either 25, 30, or 37°C in main fermentation. During main fermentation, cell growth, lactose 
consumption, acetate production, and 2-FL production were monitored. Symbols denote as 
follows; light blue circle, 25°C; green circle, 30°C; purple circle, 37°C. 
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Fig. 3.3 Batch fermentation profiles of recombinant E. coli strain JM109(DE3) harboring 
plasmids pmBCGW and pHfucT2. Effect of IPTG induction on 2-FL production was studied. 
Two IPTG concentrations (0.1 and 0.5 mM) and two times of induction (at the beginning of 
fermentation and at Dry Cell Mass (DCM) of 0.216 g/L) were compared. During the 
fermentation, cell growth, lactose consumption, acetate production, and 2-FL production were 
monitored. Symbols denote as follows; light blue circle, 0.1 mM IPTG induction at the 
beginning; green circle, 0.1 mM IPTG induction at DCM of 0.216 g/L; purple circle, 0.5 mM 
IPTG induction at the beginning; orange circle, 0.5 mM IPTG induction at DCM of 0.216 g/L. 
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Fig. 3.4 Batch fermentation profiles of recombinant E. coli strain JM109(DE3) harboring 
plasmids pmBCGW and pHfucT2. Effect of lactose availability on 2-FL production was studied. 
Lactose concentrations of 10, 15, 20, and 40 g/L were tested. During the fermentation, cell 
growth, lactose consumption, acetate production, and 2-FL production were monitored. Symbols 
denote as follows; light blue circle, lactose 10 g/L; green circle, lactose 15 g/L; purple circle, 
lactose 20 g/L; orange circle, lactose 40 g/L. 
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Fig. 3.5 Fed-batch fermentation profiles of recombinant E. coli strain JM109(DE3) harboring 
plasmids pmBCGW and pHfucT2. Optimized production conditions identified previously (pre-
culture 30°C, main fermentation 25°C, 0.1 mM IPTG induction at the beginning of fermentation, 
and lactose 15 g/L) were employed to initiate the fermentation. More lactose (of ~15 g/L each 
time) was periodically fed to the culture once it depleted to allow a continuous increase of 2-FL. 
During the fermentation, cell growth, lactose consumption, acetate production, and 2-FL 
concentration were monitored. Symbols denote as follows; light blue circle, DCM; green circle, 
lactose; purple circle, acetate; red circle, 2-FL. 
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Table 3.1 Lists of plasmids used in this study 
Name Sequence of PCR primers and description for plasmids Source 
Plasmids   
pETDuet-1 
two T7 promoters with two MCS, pBR322 replicon (copy 
number ~40), Ampr 
Merck 
Biosciences 
pCOLADuet-1 
two T7 promoters with two MCS, ColA replicon (copy 
number 10~12), Kanr 
Merck 
Biosciences 
pmBCGW 
derived from pETDuet-1, PT7-manB-manC (NcoI/SacI)-PT7-
gmd-wcaG (NdeI/XhoI)-TT7, Ampr 
Lee et al., 
2009 
pHfucT2 
derived from pCOLADuet-1, PT7- fucT2 26695 (NcoI/SacI)-
PT7-MCS2-TT7, Kanr 
Lee et al., 
2012a 
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CHAPTER IV         COMPARISON OF DIFFERENT FUCOSYLTRANSFERASES USED 
IN 2’-FUCOSYLLACTOSE PRODUCTION 
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4.1 Introduction 
 Fucosylation is defined as the transfer reaction of L-fucose from its donor, GDP-L-
fucose, to various acceptor molecules including oligosaccharides, glycoproteins, and glycolipids 
(Oriol et al., 1999). The enzymes which catalyze this reaction are known as fucosyltransferases 
(FucTs). Fucosylation yields the products containing a fucose unit, fucosylated glycans, which 
play important roles in many biological and pathological processes (Ma et al., 2006). In 
eukaryotes, fucosylated glycans are involved in tissue development, angiogenesis, fertilization, 
cell adhesion, inflammation, and tumor metastasis. Whereas in prokaryotes, fucosylation events 
occur less frequently, and fucosylated glycans may be associated with molecular mimicry, 
adhesion, colonization, and modulation of the host immune response. Fucosyltransferases can be 
categorized into four subfamilies by the position of fucose addition consisting of α1,2, α1,3/4, 
α1,6, and O-FucTs. The first three groups of FucTs are Golgi-anchored proteins (Nilsson et al., 
1993, 1996) while O-FucTs are endoplasmic reticulum (ER)-localized proteins (Luo and 
Haltiwanger, 2005; Okajima et al., 2005).   
In this study, the FucTs used for synthesis of a functional human milk oligosaccharide, 
2’-fucosyllactose (2-FL), was evaluated using Escherichia coli as a production host. 2-FL has 
been reported to strengthen the gut health since it possesses a prebiotic property supporting the 
growth of some Bifidobacteria and prevents the colonization of pathogens (Bode, 2012). The 
structure of 2-FL contains a fucose unit connected to a lactose molecule. To produce 2-FL, the 
α1,2 type FucT is required to perform fucosylation of lactose. Normally, α1,2 FucT transfers L-
fucose from GDP-L-fucose to the galactose moiety of the acceptor molecules such as N-
acetyllactosamine (LacNAc) and lactose at the α1,2 position (Ma et al., 2006) (Fig. 4.1). α1,2 
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fucosylation was reported to exist in mammals such as human, rabbits, and mice, nematode 
(Caenorhabditis elegans), parasite (Schistosoma mansoni), and bacteria (Avent, 1997; Wang et 
al., 1999a; Marques et al., 2001; Zheng et al., 2002). Fucose-containing glycans resulted from 
α1,2 fucosylation are known to be important in many biological processes. In human, α1,2 FucTs 
(FUT1 and FUT2) are responsible for synthesis of fucose-containing H-blood group antigens 
(Avent, 1997). Fucosylated glycoconjugates produced in C. elegans may be associated with 
interactions of the nematode with its environment and serve as ligands for bacterial attachment 
(Zheng et al., 2008). S. mansoni has more than 50% fucose as their glycocalyx components of 
the total sugars which are thought to play a role in the parasite’s life cycle and involve in the 
immune response and pathogenesis related to Schistosoma infection (Cummings and Nyame, 
1996, 1999). In bacteria, several putative α1,2 FucTs have been identified in a number of strains 
including E. coli, Salmonella enterica, Yersinia enterocolitica, and Helicobacter pylori (Wang et 
al., 1999a,b, 2000; Shao et al., 2003; Reeves et al., 2006; Engels and Elling, 2014). Among 
these, H. pylori α1,2 FucTs are the most well-understood enzymes with detailed analysis of the 
genes, and the main enzymes used in 2-FL synthesis studies thus far (Wang et al., 1999a,b, 2000; 
Han et al., 2012). The α1,2 FucTs in H. pylori are implicated in production of fucose-containing 
glycoconjugates known as Lewis antigens constituted in their lipopolysaccharides (LPS). The 
Lewis antigens are believed to concern the pathogenesis and adaptation of this gastric pathogen 
to the host environment (Wang et al., 1999a).  
To take a closer look at the H. pylori α1,2 FucTs, their fucT genes were described to 
contain a unique nucleotide arrangement (Fig. 4.2). The sequence consists of a poly (C) tract 
(Berg et al., 1997) and TAA repeats (may also be GAA or AAA) immediately after the poly (C) 
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sequence (Wang et al., 1999b). The changes in the repeat number of these features contribute to 
the variation in the genotype of fucT (on or off status) in different H. pylori strains. Despite the 
sequence divergence in each strain, two major genotypes can be observed in the H. pylori α1,2 
FucTs (Wang et al., 1999b). The first type as seen in the strain UA802 has an intact/single full-
length open reading frame (ORF). Therefore, the gene status is on and the full-length protein is 
always produced. The second type as noticed in the strain 26695 comprises two truncated ORFs 
as a consequence of different number of poly (C) residues (additional 2 C) from the strain 
UA802 which leads the initiating reading frame to encounter a TGA stop codon, and the 
remaining reading frame continues at about 110 basepairs further downstream where a potential 
start codon ATG appears (Wang et al., 1999b; Fig 4.2B). The production of the full-length 
protein by the second type fucT can only be possible when a perfect translation frameshift 
happens. Thus, the gene status in this case can be either on or off suggesting the full-length 
protein may not always be generated. 
Aside from the H. pylori α1,2 FucTs, a novel α1,2 FucT encoded by the gene wbgL from 
E. coli strain O126 was recently characterized and employed for a successful in vitro synthesis of 
2-FL (Engels and Elling, 2014). In the study of the substrate acceptance by WbgL, it was 
revealed that WbgL has a preference for the substrate with β4-linked galactose in the structure 
such as lactose. Therefore, it is intriguing to further explore the ability of this novel enzyme to 
produce 2-FL in vivo.   
In the whole-cell biosynthesis of 2-FL using engineered E. coli, three sources of the α1,2 
FucT (H. pylori UA802 FucT2, H. pylori 26695 FucT2, and E. coli O126 WbgL) were compared 
to identify the FucT2 leading to a high titer of 2-FL production. Several sets of fermentation 
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were conducted to compare the performance of the E. coli strains expressing different FucT2. 
Through a high cell density fed-batch fermentation, an enhanced 2-FL formation can be achieved 
in the E. coli expressing the best FucT2 from this study. 
 
4.2 Materials and methods 
 
4.2.1 Strains and plasmids 
E. coli TOP10 [F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG] was used for genetic 
manipulation. E. coli JM109(DE3) [endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-
proAB) e14- [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) (DE3)] (NEB, Ipswich, MA, 
USA) and E. coli BL21star(DE3)∆lacZ [F−, ompT, hsdSB(rB−mB−), gal, dcm rne131 (DE3) 
∆lacZ] (Chin et al., 2015) were used for production of GDP-L-fucose and 2-FL. Plasmid 
pmBCGW containing the polycistronic gmd-wcaG gene cluster and manB-manC gene cluster 
was previously constructed using plasmid pETDuet-1 (Lee et al., 2009). Plasmid pHfucT2 
harboring the gene encoding α1,2 FucT from the H. pylori 26695 strain was previously 
constructed using plasmid pCOLADuet-1 (Lee et al., 2012a).  
The gene encoding α1,2 FucT from the H. pylori UA802 strain was obtained by the 
polymerase chain reactions (PCR) using the gBlocks® gene fragment of the α1,2 fucT ORF 
(Wang et al. (1999b)’s published sequence) synthesized from Integrated DNA Technologies, 
Inc., Coralville, IA, USA as a template. Two PCR primers of fucT2-UA802_F and fucT2-
UA802_R were used for the amplification of the α1,2 fucT gene. After digestion of PCR 
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fragments of the α1,2 fucT gene and pCOLADuet-1 (Merck Biosciences, Darmstadt, Germany) 
with NcoI and SacI, the DNA fragments were ligated to construct plasmid pHUAfucT2.  
The gene encoding WbgL from E. coli O126 strain was obtained by PCR using the 
gBlocks® gene fragment of the wbgL ORF synthesized from Integrated DNA Technologies, Inc. 
as a template. Two PCR primers of wbgL_F and wbgL_R were used for the amplification of the 
wbgL gene. After digestion of PCR fragments of the wbgL gene and pCOLADuet-1 with NcoI 
and SacI, the DNA fragments were ligated to construct plasmid pEWbgL. Primers and plasmids 
used in this work are listed in Table 4.1. The constructed plasmids were confirmed by DNA 
sequencing. The conditions for PCR reaction, DNA manipulation, and bacterial transformation 
followed the descriptions in the previous study (Byun et al., 2007). 
 
4.2.2 Batch fermentation 
Batch fermentations were carried out in a small culture tube and a 250 mL shake flask 
containing 5 mL and 25 mL of Lysogeny Broth (LB) medium with suitable antibiotics at 25°C, 
respectively. Agitation speed was maintained at 300 rpm. 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) was added to the culture broth at the beginning of fermentation to 
induce protein expression. 15 g/L lactose was usually added for 2-FL conversion. A co-substrate 
in addition to lactose, if any, was also tested at 15 g/L concentration. 
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4.2.3 Fed-batch bioreactor fermentation 
 Fed-batch fermentation to compare the three FucTs was performed in a 1 L bioreactor 
(New Brunswick Bioflo®, New Brunswick Scientific, Enfield, CT, USA). The fermentation 
conditions were 25°C and 500 rpm. LB medium in the presence of appropriate antibiotics was 
used to grow the cells. pH was controlled at 6.8 using 2 N HCl and 2 N NaOH. 0.1 mM IPTG 
and initial 15 g/L lactose were added at the beginning of fermentation. Once the initial lactose 
was almost depleted, more lactose of roughly 15 g/L was replenished twice to allow a continuous 
increase of 2-FL. 
 High cell density fed-batch fermentation was performed in a 500 mL bioreactor. The 
fermentation conditions were 25°C and 500-1200 rpm. A defined medium [13.5 g/L KH2PO4, 
4.0 g/L (NH4)2HPO4, 1.7 g/L citric acid, 1.4 g/L MgSO4·7H2O, 10 mL/L trace element solution 
(10 g/L Fe(III) citrate, 2.25 g/L ZnSO4·7H2O, 1.0 g/L CuSO4·5H2O, 0.35 g/L MnSO4·H2O, 0.23 
g/L Na2B4O7·10H2O, 0.11 g/L (NH4)6Mo7O24, 2.0 g/L CaCl2·2H2O), pH 6.8] containing 20 g/L 
glycerol, 0.01 g/L Thiamine·HCl, and appropriate antibiotics was used to cultivate the cells. pH 
was maintained at 6.8 using 28% NH4OH throughout the fermentation. The high cell density 
culture was obtained through a limited feeding of either glycerol only or glycerol-mannose. The 
air flow rate was regulated so that a dissolved oxygen (DO) value can be maintained at above 
30%. The specific growth rate of the cells was administered to stay below 0.1 by adjustment of 
the feeding rate. Once the dry cell mass (DCM) reached 32 g/L, 0.1 mM IPTG and about 22 g/L 
lactose were supplemented to permit 2-FL conversion. 
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4.2.4 Analytical methods 
Cell concentration was measured by optical density (OD) at 600 nm using a 
spectrophotometer (Biomate 5, Thermo, NY, USA). Dry cell mass was calculated using an 
estimate of 0.36 gram cells per OD value of 1. Concentrations of lactose, mannose, glycerol, 
fructose, xylose, 2-FL, and acetate in batch and fed-batch fermentations were determined using a 
high performance liquid chromatography (HPLC) system (Agilent Technologies 1200 Series) 
equipped with a Rezex ROA Organic Acid H+ column (Phenomenex, Torrance, CA, USA) and a 
refractive index (RI) detector (Agilent, Palo Alto, CA, USA). The column was eluted with 0.005 
N H2SO4 at a flow rate of 0.6 mL/min at 50°C. 
 
4.3 Results 
  
4.3.1 Production of 2-FL in engineered E. coli JM109(DE3) expressing different 
fucosyltransferases in shake flask fermentation 
The performance of the engineered JM109(DE3) overexpressing the GDP-L-fucose 
synthesizing genes and expressing different fucT2 (one-ORF H. pylori fucT2, two-ORF H. pylori 
fucT2, or E. coli fucT2 (wbgL)) on 2-FL production was evaluated (Fig. 4.3). 15 g/L lactose was 
supplemented in the culture medium for growth and 2-FL conversion.  
In terms of cell growth, the one-ORF strain grew from DCM 0.036 to 4.9 g/L within 80 
h. Within the same timeframe, the two-ORF strain multiplied a little slower to DCM 4.5 g/L 
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from the same initial cell concentration. The WbgL strain grew as well as the other two strains 
during the exponential phase, but later reached a lower DCM (3.9 g/L) than the others.   
 In regard to lactose consumption, the two H. pylori FucT2 strains behaved similarly and 
had almost the same rate of lactose fermentation (15 g/L was consumed within about 80 h). 
Interestingly, the WbgL strain assimilated lactose significantly faster than the other two strains 
(lactose was all finished in an estimate of 70 h).  
 Acetate is an unwanted by-product commonly excreted by E. coli in aerobic fermentation 
(Farmer and Liao, 1997). Acetate formation occurs as an outcome of rapid sugar consumption 
causing the overflow of carbon flux from acetyl-coenzyme A (CoA) to acetate instead of 
Tricarboxylic acid (TCA) cycle (Hollywood and Doelle, 1976). Between the H. pylori FucT2 
strains, the one-ORF strain generated a higher acetate (0.21 g/L) than the two-ORF strain (0.08 
g/L) during the fast lactose consumption period. However, acetate was re-assimilated by the cells 
afterward. Surprisingly, the WbgL strain did not secrete any acetate over the course of 
fermentation when it had the highest lactose assimilation rate.  
 Regarding 2-FL synthesis, the strain harboring one-ORF FucT2 produced the highest    
2-FL (1.1 g/L). The two-ORF and WbgL strains produced 0.8 and 0.4 g/L of 2-FL, respectively.  
 
4.3.2 Production of 2-FL in engineered E. coli JM109(DE3) expressing different 
fucosyltransferases in fed-batch bioreactor fermentation 
The engineered JM109(DE3) overexpressing the GDP-L-fucose synthesizing genes and 
expressing different fucT2 (one-ORF H. pylori fucT2, two-ORF H. pylori fucT2, or E. coli fucT2 
(wbgL)) was further assessed in a larger scale fermentation (1 L) to confirm the best FucT2 
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contributing to the highest amount of 2-FL (Fig. 4.4). 15 g/L lactose was supplemented in the 
culture medium at the beginning and continued to replenish once the previous supply was almost 
depleted to allow a higher accumulation of 2-FL.  
In terms of cell growth, the one-ORF and two-ORF strains grew similarly to DCM 5.4 
g/L. The WbgL strain grew not as well as the other two strains reaching DCM of 4.3 g/L.   
 In regard to lactose consumption, the two H. pylori FucT2 strains consumed lactose at 
almost the same rate throughout the fermentation. The WbgL strain displayed a slightly faster 
lactose assimilation rate in the initial round of lactose. However, its speed in consumption 
seemed to start slowing down as more lactose was added.  
 Regarding acetate accumulation, only a negligible amount of acetate (0.1 g/L) was 
detected in the two-ORF strain. No acetate was accumulated in this experiment possibly due to a 
highly-aerobic condition in a bioreactor which has continuous high rpm agitation and air coming 
in the vessel.  
 For 2-FL synthesis, the strain harboring the one-ORF FucT2 is clearly the best among 
the three strains with a 2-FL titer of 4.2 g/L. The two-ORF and WbgL strains produced 2.2 and 
2.1 g/L of 2-FL, respectively.  
 
4.3.3 Production of 2-FL in engineered E. coli BL21star(DE3)∆lacZ expressing the H. 
pylori one-ORF fucosyltransferase in the presence of lactose and a co-substrate 
To further increase the 2-FL or any product titer in the whole-cell biosynthesis system, a 
high cell density fermentation technique is generally exploited. By taking advantage of a high 
cell concentration, the overall production of a target compound can be enhanced from the sum of 
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the product produced by each cell. Nevertheless, the E. coli JM109(DE3) may not be a good host 
strain for the high cell density experiment. The JM109 strain usually secretes a lot of 
exopolysaccharides (EPS) to the surrounding medium. When the strain is grown to a high cell 
density, an even larger amount of EPS produced from a numerous amount of cells can be 
observed. The excess amount of EPS creates a viscous growth medium leading to an inefficient 
oxygen transfer and acetate build-up. For these reasons, the host strain for 2-FL production was 
altered to E. coli BL21star(DE3)∆lacZ. The BL21 strain has been widely employed for a 
successful high cell density fermentation (Lee, 1996).   
To thoroughly understand the discrepancy of the new host strain, BL21, and the previous 
strain, JM109, in detail, the BL21 strain series naturally ferment lactose efficiently owing to a 
fully active lac operon unlike the JM109 strain. The JM109 strain is actually known to be unable 
to utilize lactose due to an M15 mutation (an alpha region of β-galactosidase (lacZ) is deleted). 
However, the DE3 portion in JM109(DE3) strain contains the alpha sequence of lacZ in addition 
to the T7 RNA polymerase allowing the JM109(DE3) strain to grow on lactose through the alpha 
complementation although at a slower rate than other natural lactose-fermenting E. coli (Dumon 
et al., 2004). In order to produce 2-FL using the BL21 strain, the BL21star(DE3) with deletion of 
lacZ gene (BL21star(DE3)∆lacZ) from Chin et al. (2015) was selected. The ∆lacZ strain was 
used as a host strain in order to preserve intact lactose for 2-FL conversion. The wild-type strain 
would instead hydrolyze lactose and utilize it for cell growth rather than conserving it for 2-FL 
synthesis (Lee et al., 2012a). 
It was predicted that the new host, BL21star(DE3)∆lacZ, might not be able to grow on 
lactose as a sole carbon source because of the absence of lacZ gene. Consequently, a co-sugar 
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substrate in addition to lactose might be needed to support cell growth while lactose is mostly 
used to convert to 2-FL. In this fermentation, four different co-substrates comprising mannose, 
fructose, glycerol, and xylose were tested to find out the co-substrate which worked well with 
lactose to produce the highest amount of 2-FL (Fig. 4.5). As anticipated, the BL21star(DE3) 
∆lacZ was not able to grow on lactose only. The best co-substrate was mannose which 
contributed to the highest titer of 2-FL (1.6 g/L) with the least amount of acetate. The second 
best co-feeding sugar was xylose which had about 0.5 g/L 2-FL. However, 2-FL was barely 
produced under fructose and glycerol conditions. 
 
4.3.4     High cell density fermentation of 2-FL in engineered E. coli BL21star(DE3)∆lacZ 
expressing the H. pylori one-ORF fucosyltransferase under the sole glycerol and the 
glycerol-mannose feeding 
 As mannose was discovered to be a good co-substrate benefiting 2-FL production, 
supplementation of mannose after IPTG induction in a high cell density fermentation was 
thought to enhance the GDP-L-fucose production leading to an improved 2-FL production. 
Mannose was not employed to support cell growth from the beginning of fermentation because a 
continuous feeding of a concentrated mannose solution would be relatively expensive. Instead, 
glycerol was decided as the main feeding sugar to bring the culture to the high cell density. 
Glycerol has been successfully used to achieve the high cell density culture of E. coli by 
previous researchers (Baumgartner et al., 2013; Chin et al., 2015). Moreover, the growth of       
E. coli on glycerol is generally slower than that on glucose. Acetate production can be minimized 
in a slower sugar metabolism condition.  
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 In this high cell density fermentation experiments, effect of a mannose boost on 2-FL 
production was evaluated. Fig. 4.6 and 4.7 display the fermentation profiles of the sole glycerol 
feeding and the glycerol-mannose feeding conditions, respectively. In regard to cell growth, the 
E. coli BL21star(DE3)∆lacZ was able to grow under a sugar-limited feeding to the final DCM of 
76.3 g/L in both conditions. Glycerol feeding was regulated in order to maintain the cell specific 
growth rate (µ) below 0.1. Hence, the glycerol concentration was kept close to zero throughout 
the fermentation to avoid the too high µ and a rapid sugar metabolism which may result in 
acetate production. However, the accumulation of glycerol was observed during the early 
exponential growth despite the careful control of glycerol feeding rate. This glycerol build-up led 
to acetate production of 1.2 and 0.5 g/L in the sole glycerol and glycerol-mannose conditions, 
respectively. After the pause of sugar feeding, acetate was re-assimilated by the cells. Once the 
culture reached the DCM of about 32 g/L, 0.1 mM IPTG and about 22 g/L lactose were added to 
the culture medium to allow the protein expression and 2-FL conversion, respectively. In the 
glycerol-mannose feeding, the feeding carbon source was changed from glycerol to mannose 
after IPTG induction. The mannose boost lasted about 30 h and the feeding sugar was switched 
back to glycerol. Interestingly, the E. coli BL21star(DE3)∆lacZ in both conditions produced the 
same 9 g/L of 2-FL by the end of the fermentation. This result suggested that the mannose boost 
was not really important to achieve an enhanced 2-FL production in the high cell density 
fermentation. The yields of 2-FL (g 2-FL/g lactose) are 0.2 and 0.4 in the sole glycerol and 
glycerol-mannose conditions, respectively. 
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4.4 Discussion 
 Fucosyltransferases (FucTs) are a group of enzymes which catalyze the transfer reaction 
of fucose from GDP-L-fucose to various acceptor molecules such as carbohydrates, protein, and 
lipids. These fucose-containing glycoconjugates are described to be crucial in many biological 
processes mostly involved in antigen synthesis, pathogenesis, and adaptation to host enviroment 
of the organism. In the context of 2-FL production, FucT which transfers fucose to α1,2 position 
of the acceptor molecule known as α-1,2-fucosyltransferase (FucT2) is of interest. FucT2 from 
Helicobacter pylori is the most well-understood and detailedly characterized. Two major 
genotypes of H. pylori FucT2 were identified. The first genotype as seen in H. pylori strain 
UA802 contains a single full-length ORF. The second genotype as seen in H. pylori strain 26695 
consists of two truncated ORFs. The production of a full-length protein in the second case relies 
solely on a perfect translation frameshift. Previously, many research groups successfully 
produced 2-FL by means of whole-cell biosynthesis using FucT2 from strain 26695 with two-
ORF genotype (Drouillard et al., 2006; Lee et al., 2012a; Baumgartner et al., 2013; Chin et al., 
2015). Despite the dependency of the full-length protein production on the perfect frameshift, 
over 20 g/L of 2-FL was excellently made in a fed-batch fermentation using FucT2 with two-
ORF version (Baumgartner et al., 2013). Besides, the recently characterized FucT2 from E. coli 
strain O126, WbgL, is also in spotlight. 2-FL was successfully produced in the in vitro assay 
containing the crude extract of the E. coli expressing wbgL (Engels and Elling, 2014). 
 In this study, FucT2 from a different strain of H. pylori, UA802, and the novel FucT2 
from E. coli O126 (WbgL) were compared with FucT2 from the strain 26695 for the first time in 
regard to 2-FL production. In shake flask fermentation of JM109(DE3) expressing fucT2 from 
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three different origins, the one-ORF strain performed the best resulting in 2-FL production of 1.1 
g/L from 15 g/L lactose. The apparent advantage of the one-ORF FucT2 over the two-ORF 
FucT2 is that its produced protein is always functional. A greater amount of functional FucT2 
protein would contribute to the more efficient conversion of lactose to 2-FL. The result 
suggested that the event of the perfect translation frameshift in the two-ORF genotype might 
happen at about 70% chance since the 2-FL made by the two-ORF strain was about 70% of the 
one-ORF strain. So far it is unknown about the frequency of the perfect frameshift and whether 
the number of the frameshift occurrence is consistent every time. With the goal to overproduce 
2-FL, expression of the one-ORF FucT2 might be more reliable. For the WbgL strain, it is 
unclear why the strain produced the least 2-FL. The E. coli expressing WbgL fermented lactose 
the fastest. This may be explained by the high affinity of WbgL toward lactose as an acceptor as 
described by Engels and Elling (2014). If this is really the case, it is still confusing where exactly 
the consumed lactose went since it did not seem to go to biomass, 2-FL, nor acetate. 
 In a fed-batch fermentation in a bioreactor to compare the three FucT2s, the one-ORF 
FucT2 strain was proved to be the best among all the tested FucT2. The final titer of 2-FL (4.2 
g/L) from this strain was two times greater than that (2.1-2.2 g/L) from the two-ORF and WbgL 
strains. The exact explanation for the superiority of the one-ORF strain over the other two strains 
cannot be concluded without the future experiments to look at the quantity and expression of the 
three proteins in detail.  
To further improve the 2-FL or any product titer, the technique of using a high cell 
density culture is often selected by many researchers. The host strain to produce 2-FL had to be 
switched from JM109(DE3) to BL21star(DE3)∆lacZ because the JM109 strain had difficulty 
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going to a high cell density due to the culture viscosity. Hence, the BL21 strain with deactivation 
of lacZ was chosen for the experiment in order to conserve intact lactose for 2-FL synthesis. 
However, the BL21star(DE3)∆lacZ needed a co-sugar substrate beside lactose to grow. Mannose 
was found to be the best among the tested sugars yielding the highest amount of 2-FL (1.6 g/L). 
This is probably because mannose is the closest sugar to the synthesis of GDP-D-mannose, a 
precursor of GDP-L-fucose. Xylose showed a potential to be a great co-substrate in 2-FL 
production with the second highest concentration of 2-FL (0.5 g/L). It may be possible that 
xylose is a non-repressing sugar so it permits a more efficient lactose uptake than other tested 
sugars. In Saccharomyces cerevisiae, xylose has been declared to be a good carbon source to 
produce products other than ethanol (Kwak et al., in preparation). In fructose and glycerol 
conditions, 2-FL production was not noticed. Instead, a considerable amount of acetate of over 1 
g/L was generated. Acetate is known to negatively affect the recombinant protein production. It 
is doubtful whether acetate was the true reason for no 2-FL production or the sugars themselves 
are the problems. If this fermentation was performed in a better aerated condition (i.e. a 
bioreactor), the acetate formation could have been less and some 2-FL might have beeen made. 
Therefore, repetition of the experiments in the future may be considered to confirm the results.  
 In a high cell density fed-batch fermentation with the one-ORF FucT2 strain, the 
mannose boost was not really helpful to increase the 2-FL production. It is possible that the boost 
did not last a long time (30 h) so the benefit of the boost on 2-FL synthesis was not obvious. In 
the future endeavor, GDP-L-fucose concentration inside the cells may be measured to determine 
whether the mannose addition literally increases the GDP-L-fucose concentration as compared 
with the condition without mannose. Although the final titer of 2-FL from the two feeding 
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conditions (glycerol only and glycerol-mannose) is the same (9 g/L), the yield of 2-FL from 
lactose in the glycerol-mannose feeding is better (0.4 vs. 0.2 g/g). This indicated the need of less 
amount of lactose in the glycerol-mannose condition to get the same amount of 2-FL formation 
as the glycerol only condition. However, the utilization of more lactose is not a concern in reality 
since lactose is an inexpensive carbon source. Mannose, in fact, is much more costly than 
lactose. 
 Based on the results from this study, H. pylori one-ORF FucT2 (strain UA802) is the best 
choice to be used in constructing a 2-FL-producing E. coli. The genotype background with one 
full-length ORF guarantees the consistent production of a full-length protein leading to a better 
and more stable 2-FL production. The two-ORF situation depends on the uncertainty of the 
perfect frameshift, thus a large variation of 2-FL production may be expected. Little knowledge 
is known about the wbgL expression in E. coli. More research related to protein expression of 
these enzymes may be needed. Nevertheless, future studies should be directed toward 
improvement of the FucT2 protein expression in a soluble form to maximize 2-FL production as 
often times inclusion bodies have been a persistent problem in protein expression in E. coli. 
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4.5 Figures and tables 
 
Fig. 4.1 The α-1,2-fucosyltransferase (FucT2) activity in 2’-fucosyllactose (2-FL) production. 
FucT2 catalyzes the transfer reaction of L-fucose from GDP-L-fucose onto lactose at a 2’ 
position of the galactose unit to convert to 2-FL. The released GDP can be recycled to synthesize 
more GDP-L-fucose. 
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Fig. 4.2 Different open reading frame (ORF) structures of FucT2 in strains 26695 and UA802. 
26695 ORF is split into two ORFs of 0094 and 0093 while UA802 ORF is complete as one full-
length ORF (A). The hypermutable region of fucT2 sequence. 26695 has extra 2 C bases during 
the poly C tract. This incident leads 26695 to encounter a TGA stop codon in the initiating 
reading frame. In the further downstream sequence, an ATG start codon appears which is the 
beginning of the remaining (second) reading frame (B) (Wang et al., 1999b). 
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Fig. 4.3 Batch fermentation profiles of recombinant E. coli JM109(DE3) harboring plasmid 
pmBCGW and a different plasmid for FucT2 expression consisting of pHUAfucT2 (one-ORF H. 
pylori FucT2 UA802), pHfucT2 (two-ORF H. pylori FucT2 26695), and pEWbgL (E. coli O126 
FucT2 (WbgL)). Fermentations were performed in shake flasks in the presence of 15 g/L lactose. 
2-FL formation by E. coli expressing different FucT2 was compared. Line colors on the charts 
denote as follows; blue, one-ORF H. pylori FucT2; green, two-ORF H. pylori FucT2; orange,   
E. coli FucT2 (WbgL). Measurement of cell, lactose, acetate, and 2-FL concentrations was 
calculated from two independent experiments. 
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Fig. 4.4 Fed-batch fermentation profiles of recombinant E. coli JM109(DE3) harboring plasmids 
pmBCGW and a different plasmid for FucT2 expression consisting of pHUAfucT2 (one-ORF H. 
pylori FucT2 UA802), pHfucT2 (two-ORF H. pylori FucT2 26695), and pEWbgL (E. coli O126 
FucT2 (WbgL)). Fermentations were performed in a 1 L bioreactor in the presence of initial 15 
g/L lactose. More lactose (of ~15 g/L each round) was periodically fed to the culture once it 
depleted to allow a continuous increase of 2-FL. Throughout the fermentation, cell growth, 
lactose consumption, acetate production, and 2-FL concentration were monitored. Line colors on 
the charts denote as follows; blue, one-ORF H. pylori FucT2; green, two-ORF H. pylori FucT2; 
orange, E. coli FucT2 (WbgL). 
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Fig. 4.5 Batch fermentation profiles of recombinant E. coli BL21star(DE3)∆lacZ harboring 
plasmids pmBCGW and pHUAfucT2 (one-ORF H. pylori FucT2 UA802). Fermentations were 
performed in a 5 mL culture tube in the presence of 15 g/L lactose and 15 g/L of different co-
substrates. 2-FL formation in the presence of different co-substrates was compared. The co-
substrates studied included mannose, fructose, glycerol, and xylose. Line colors on the charts 
denote as follows; purple, lactose only; red, lactose and mannose; blue, lactose and fructose; 
green, lactose and glycerol; orange, lactose and xylose. Measurement of cell, lactose, mannose, 
fructose, glycerol, xylose, acetate, and 2-FL concentrations was calculated from two independent 
experiments. 
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Fig. 4.6 Glycerol-limited fed-batch fermentation profiles of recombinant E. coli 
BL21star(DE3)∆lacZ harboring plasmids pmBCGW and pHUAfucT2 (one-ORF H. pylori 
FucT2 UA802). Fermentation was performed in a 500 mL bioreactor in the presence of initial 20 
g/L glycerol. Glycerol-limited feeding was started after the initial glycerol was exhausted. The 
feeding rate was progressively altered and controlled in order to maintain the cell specific growth 
rate of below 0.1. Once the dry cell mass (DCM) reached 32, 0.1 mM IPTG and 22 g/L lactose 
were added to induce protein expression and 2-FL conversion, respectively. Glycerol was solely 
used to support the cell growth throughout the fermentation. Line colors on the chart denote as 
follows; orange, DCM; dark blue, lactose; light blue, glycerol; red, 2-FL; green, acetate. A black 
arrow indicated the time of IPTG and lactose addition. 
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Fig. 4.7 Glycerol-mannose-limited fed-batch fermentation profiles of recombinant E. coli 
BL21star(DE3)∆lacZ harboring plasmids pmBCGW and pHUAfucT2 (one-ORF H. pylori 
FucT2 UA802). Fermentation was performed in a 500 mL bioreactor in the presence of initial 20 
g/L glycerol. Glycerol-limited feeding was started after the initial glycerol was exhausted. The 
feeding rate was progressively altered and controlled in order to maintain the cell specific growth 
rate of below 0.1. Once the dry cell mass (DCM) reached 32, 0.1 mM IPTG and 23 g/L lactose 
were added to induce protein expression and 2-FL conversion, respectively. The feeding sugar 
was also changed from glycerol to mannose. The impact of mannose on boosting 2-FL 
production was interested. Mannose was used to support cell growth for about 30 h. Then, the 
feeding carbon source was switched back to glycerol for the rest of the fermentation. Line colors 
on the chart denote as follows; orange, DCM; dark blue, lactose; light blue, glycerol; purple, 
mannose; red, 2-FL; green, acetate. A black arrow indicated the time of IPTG and lactose 
addition. 
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Table 4.1 Lists of primers and plasmids used in this study 
Name Sequence of PCR primers and description for plasmids Source 
PCR primers   
fucT2-UA802_F 
(NcoI) 
5’-TCTACAGCGGCCGCCCATGGGCGCCTTCAAA-3’ 
H. pylori 
UA802 fucT2-UA802_R 
(SacI) 
5’-TACAACGCAGAGCTCGCGGCCGCTCTATA-3’ 
wbgL_F (NcoI) 5’-TCTACAGCGGCCGCCCATGGGCAGCATCATT-3’ 
E. coli O126 
wbgL_R (SacI) 5’-AGCTGTTAAGAGCTCGCGGCCGCTCTATA-3’ 
Plasmids   
pETDuet-1 
two T7 promoters with two MCS, pBR322 replicon (copy 
number ~40), Ampr 
Merck 
Biosciences 
pCOLADuet-1 
two T7 promoters with two MCS, ColA replicon (copy 
number 10~12), Kanr 
Merck 
Biosciences 
pmBCGW 
derived from pETDuet-1, PT7-manB-manC (NcoI/SacI)-PT7-
gmd-wcaG (NdeI/XhoI)-TT7, Ampr 
Lee et al., 
2009 
pHfucT2 
derived from pCOLADuet-1, PT7- fucT2 26695 (NcoI/SacI)-
PT7-MCS2-TT7, Kanr 
Lee et al., 
2012a 
pHUAfucT2 
derived from pCOLADuet-1, PT7- fucT2 UA802 (NcoI/SacI)-
PT7-MCS2-TT7, Kanr 
This study 
pEWbgL 
derived from pCOLADuet-1, PT7- fucT2 UA802 (NcoI/SacI)-
PT7-MCS2-TT7, Kanr 
This study 
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CHAPTER V          ATTEMPT TO PRODUCE 2’-FUCOSYLLACTOSE IN 
SACCHAROMYCES CEREVISIAE 
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5.1 Introduction 
 Saccharomyces cerevisiae has a long history in fermentation and baking. It is naturally 
known as an ethanol producer as lected in the products derived from this yeast in food and 
beverage industries. By manipulation of the cell metabolism, the exploitation of this yeast can be 
broadened to create numerous products other than ethanol such as lactic acid (Skory, 2003) and 
xylitol (Hallborn et al., 1991). As a host strain to produce value-added products, the popularity of 
S. cerevisiae has been increasing owing to the ease of its cultivation, the wide availability of its 
genetic tools, and its Generally Recognized As Safe (GRAS) status. 
 One interesting area remaining unexplored in S. cerevisiae is production of human milk 
oligosaccharides (HMOs). HMOs confer many health benefits to the host including stimulating 
the growth of select Bifidobacteria (prebiotic effect), serving as receptor analogs for pathogens, 
and modulating immune responses (Bode, 2012). Synthesis of various HMOs has been attempted 
mostly in Escherichia coli and Corynebacterium glutamicum (Han et al., 2012). S. cerevisiae, in 
fact, could be a great host to produce certain HMOs such as fucosylated HMOs due to a few 
reasons. It has a rich intracellular pool of GDP-D-mannose since mannosylation is the major 
glycosylation reaction occurred in yeast (Mattila et al., 2000). As GDP-D-mannose is a substrate 
of GDP-L-fucose in the de novo pathway, this gives an advantage to produce GDP-L-fucose, a 
donor of L-fucose, required in fucosylation reactions. As a GRAS organism, S. cerevisiae 
secreting HMOs may replace the traditional yeast to generate functional food products without 
the need to purify HMOs out of the fermentation or the concern regarding enterotoxin carryover 
like in E. coli.   
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 2’-fucosyllactose (2-FL), one of the most studied HMOs, has the most basic structure of 
fucosylated HMOs with one fucose unit connected to lactose on the galactose end. 2-FL has been 
demonstrated the protective activity against several pathogenic microorganisms such as 
Campylobacter jejuni, Enteropathogenic E. coli, Salmonella enterica, and Norovirus 
(Etzold and Bode, 2014; Weichert et al., 2013). A great success was achieved in whole-cell 
biosynthesis of 2-FL using E. coli with the highest titer of 20.3 g/L (Baumgartner et al., 2013). 
To date, no 2-FL synthesis in yeast has been recorded. As discussed previously, it would be 
worthwhile to enable yeast to produce 2-FL since this yeast can be employed in miscellaneous 
applications and provide additional health benefits and values to the products.  
 To construct an S. cerevisiae strain capable of producing 2-FL, at least three goals must 
be accomplished (Fig. 5.1). First, as a primary substrate for 2-FL synthesis, GDP-L-fucose needs 
to be intracellularly available. Two heterologous genes consisting of GDP-D-mannose-4, 6-
dehydratase (gmd) and GDP-4-keto-6-deoxymannose-3, 5-epimerase-4-reductase (wcaG) are 
obliged to convert the inherent GDP-D-mannose into GDP-L-fucose (Mattila et al., 2000). 
Additionally, GDP-L-fucose production may be enhanced by further genetic perturbations. For 
instance, GDP-D-mannose pyrophosphorylase (PSA1) is the enzyme which catalyzes the final 
step of GDP-D-mannose formation. Overexpression of PSA1 was claimed to raise the cellular 
content of GDP-D-mannose (Janik et al., 2003). Hence, PSA1 may be an interesting gene target 
for improvement of GDP-L-fucose concentration through the increase of GDP-D-mannose. 
Another prospective target, GDA1, which encodes for guanosine diphosphatase (GDPase), 
involves in the translocation of GDP-D-mannose into the golgi (Fig. 5.2). In normal S. 
cerevisiae, once GDP-D-mannose is produced in the cytosol, it is then transported into the golgi 
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to supply mannose for various mannosylation reactions. However, this migration of GDP-D-
mannose to the golgi is unfavorable for GDP-L-fucose production because the cytosolic 
availability of GDP-D-mannose becomes insufficient for converting to GDP-L-fucose. The 
GDP-D-mannose golgi transporter is an antiporter type which demands the exit of GMP to the 
cytosol as GDP-D-mannose enters the golgi. GDA1 plays a role in converting GDP to GMP 
when GDP is released from GDP-D-mannose inside the golgi. Deletion of GDA1 causes an 
inadequacy of GMP export which subsequently leads to the 5-fold decrease of the GDP-D-
mannose import into the golgi lumen (Berninsone et al., 1994). Accordingly, GDA1 knockout 
may be useful for GDP-L-fucose synthesis since GDP-D-mannose retains more in the cytosol.  
 Second, another substrate, lactose, should be transported into the cytosol where GDP-L-
fucose is made. Native S. cerevisiae cannot metabolize nor import lactose. Further genetic 
modifications are then necessary to acquire the S. cerevisiae strain able to ingest lactose. A 
lactose permease from other organisms such as LacY from E. coli, LAC12 from Kluyveromyces 
lactis (Chang and Dickson, 1988), or CDT-1 from Neurospora crassa (Galagan et al., 2003) 
needs to be introduced into the wild-type S. cerevisiae in order to permit the uptake of the 
external lactose into the cytosol. A β-galactosidase (β-gal) which breaks down lactose into 
glucose and galactose is presumably needless in this situation. The intact lactose should be 
preserved for conversion to 2-FL. In addition, a successful production of 2-FL in E. coli with 
deactivation of the β-gal has been validated indicating the probable nonnecessity of the β-gal in 
the yeast system (Chin et al., 2015).  
Third, the α-1,2-fucosyltransferase (FucT2) enzyme which catalyzes the transfer reaction 
of L-fucose from GDP-L-fucose to lactose through an α-1,2 linkage has to be expressed in the 
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cytosol. Since S. cerevisiae does not naturally perform fucosylation, an insertion of the 
heterologous FucT2 is unavoidable. So far, only FucT2s from Helicobacter pylori (Albermann et 
al., 2001; Baumgartner et al., 2013; Chin et al., 2015; Drouillard et al., 2006; Lee et al., 2012a) 
and a few E. coli strains (Engels and Elling, 2014; Shao et al., 2003) have been studied in the 
context of 2-FL biosynthesis.  
 In this study, the three elements anticipated to induce 2-FL synthesis were introduced in 
S. cerevisiae separately for the initial confirmation that each part was functionally expressed. 
First, GMD and WcaG from E. coli K-12 were expressed in S. cerevisiae to empower GDP-L-
fucose production. Moreover, enhanced GDP-L-fucose production was accomplished. The effect 
of two mutations including PSA1 overexpression and GDA1 knockout on GDP-L-fucose 
production was investigated. Second, lactose transporters including CDT-1 and LAC12 were 
coupled with GH1-1 (a β-glucosidase which was discovered to also exhibit the β-gal activity; Liu 
et al., 2015 (in preparation)) and LAC4 (a β-gal from K. lactis; Sreekrishna and Dickson, 1985) 
to create the S. cerevisiae strain capable of assimilating lactose. Third, the FucT2 from H. pylori 
was expressed in S. cerevisiae. The FucT2 activity was then confirmed in the in vitro 2-FL 
synthesis assay. Although 2-FL was not yet observed when the three components were altogether 
incorporated in S. cerevisiae, the findings in this study would provide helpful information for any 
future endeavor related to engineering S. cerevisiae to produce GDP-L-fucose and 2-FL. 
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5.2 Materials and methods 
 
5.2.1 Strains and plasmids 
E. coli TOP10 [F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG] was used for transformation of 
the constructed plasmids. S. cerevisiae D452-2 (MATalpha, LEU2, HIS3, URA3, and CAN1) was 
used as a host strain to verify GDP-L-fucose production, lactose assimilation, and FucT2 
expression.  
For GDP-L-fucose synthesis, gmd and wcaG genes were obtained by the polymerase 
chain reactions (PCR) using the genomic DNA of E. coli K-12 as a template. Two PCR primers 
of gmd_F and gmd_R were used for the amplification of the gmd gene. After digestion of PCR 
fragments of the gmd gene and pRS423GPD plasmid with SpeI and ClaI, the DNA fragments 
and the plasmid were ligated to construct plasmid pRS423GPD-gmd. Similarly, the wcaG gene 
was amplified by two PCR primers (wcaG_F and wcaG_R). The wcaG gene fragments and 
pRS425GPD plasmid were digested with BamHI and HindIII, and then ligated to construct 
plasmid pRS425GPD-wcaG.  
To enable S. cerevisiae to assimilate lactose, two lactose transporters consisting of cdt-1 
(MFS lactose permease; Galagan et al., 2003/cellodextrin transporter; Galazka et al., 2010) and 
LAC12 (lactose permease; Chang and Dickson, 1988) genes were cloned into pRS423PGK and 
pRS423GPD plasmids, respectively. pRS423PGK-cdt-1 was constructed previously 
(construction detail can be found in Oh et al., 2015 (in preparation)). LAC12 gene was acquired 
by PCR using the genomic DNA of K. lactis (NRRL: Y-8279) as a template. The LAC12 gene 
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which was amplified by two primers (LAC12_F and LAC12_R) and pRS423GPD plasmid were 
treated with SpeI and SalI, and then ligated to construct plasmid pRS423GPD-LAC12. In 
addition to the lactose transporters, two lactose-hydrolyzing genes comprising gh1-1 (β-
glucosidase; Liu et al., 2015 (in preparation)) and LAC4 (β-galactosidase; Sreekrishna and 
Dickson, 1985) were cloned into pRS425PGK and pRS425GPD plasmids, respectively. 
pRS425PGK-gh1-1 was constructed previously (construction detail can be found in Oh et al., 
2015 (in preparation)). LAC4 gene was attained by PCR using the genomic DNA of K. lactis 
(NRRL: Y-8279) as a template. The LAC4 gene which was amplified by two primers (LAC4_F 
and LAC4_R) and pRS425GPD plasmid were digested with SpeI and SalI, and then ligated to 
construct plasmid pRS425GPD-LAC4. 
For expression of FucT2, the fucT2 gene from H. pylori strain 26695 was acquired by 
PCR using plasmid pHfucT2 from Lee et al. (2012a) as a template. Primers (fucT2-26695_F and 
fucT2-26695_R) were employed to amplify the fucT2 gene from strain 26695. The gene 
fragments and plasmid pRS426GPD were then treated with BamHI and ClaI, and ligated to 
construct plasmid pRS426GPD-fucT2-26695. The fucT2 gene from a different strain of H. pylori 
(UA802) was also tested. The fucT2 open reading frame from strain UA802 was codon-
optimized for S. cerevisiae and synthesized using the gBlocks® service from Integrated DNA 
Technologies, Inc. The fucT2 UA802 gene was then amplified by primers (fucT2-UA802_F and 
fucT2-UA802_R) in a PCR using the synthesized DNA as a template. The gene fragments and 
plasmid pRS426GPD were digested with BamHI and ClaI, and ligated to construct plasmid 
pRS426GPD-fucT2-UA802. 
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Primers and plasmids used in this work are listed in Tables 5.1 and 5.2, respectively. All 
constructed plasmids were confirmed by DNA sequencing. 
 
5.2.2 Construction of S. cerevisiae capable of producing GDP-L-fucose using CRISPR-
Cas genome-editing technique 
 The following procedures for genome engineering were adapted from DiCarlo et al. 
(2013) which describes the application of clustered regularly interspaced short palindromic 
repeat (CRISPR)-Cas system in S. cerevisiae. Initially, the two genes necessary for GDP-L-
fucose production, gmd and wcaG, were chromosomally integrated into S. cerevisiae D452-2. 
Cas9 plasmid constructed previously (Zhang et al., 2014) was transformed into the D452-2 
strain. The first repair DNA of 2.2 kb including the expression cassette of GPDp-gmd-CYC1t 
was PCR amplified by primers gmd-donor_F and gmd-donor_R using plasmid pRS423GPD-gmd 
as a template. The forward and reverse primers have 62 and 65 base-overhangs which are 
sequences located upstream and downstream of the target integration site, respectively. The 
overhangs on both ends of the repair DNA are needed to provide homology for the repair DNA 
to fix a double-strand break occurred due to Cas9 cutting. The target site for gmd integration is 
the intergenic region between SPB1 and PBN1 genes. Then, the guide RNA (gRNA) plasmid 
containing the target sequence of the SPB1-PBN1 site constructed previously (Lane et al., in 
preparation) together with the repair DNA of the gmd expression cassette were transformed into 
the Cas9-expressing D452-2 to generate the gmd-expressing D452-2 strain through genome 
integration without disrupting any native genes.   
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 To further integrate wcaG into the genome, the second repair DNA of 2.1 kb including 
the expression cassette of GPDp-wcaG-CYC1t was PCR amplified by primers wcaG-donor_F 
and wcaG-donor_R using plasmid pRS425GPD-wcaG as a template. The forward and reverse 
primers have 39 and 42 base-overhangs which are sequences located upstream and downstream 
of the target integration site, respectively. The target site for wcaG integration is the intergenic 
region between CRH1 and HIP1 genes. Then, the gRNA plasmid containing the target sequence 
of the CRH1-HIP1 site constructed previously (Xu et al., in preparation) together with the repair 
DNA of the wcaG expression cassette were transformed into the D452-2 expressing Cas9 and 
gmd to generate the D452-2 expressing gmd and wcaG (D452-2 gmd wcaG) without disrupting 
any native genes.   
  In the enhancement of GDP-L-fucose production experiment, the overexpression target, 
PSA1 gene was acquired by PCR using the genomic DNA of D452-2 as a template. The PSA1 
gene which was amplified by two primers (PSA1_F and PSA1_R) and pRS426GPD plasmid 
were treated with BamHI and ClaI, and then ligated to construct plasmid pRS426GPD-PSA1. 
Next, the expression cassette of GPDp-PSA1-CYC1t was integrated into the chromosome 
through the CRISPR-Cas system. The primer pair consisting of PSA1-donor_F and PSA1-
donor_R was employed to amplify the repair DNA which is the PSA1 expression cassette of 2.2 
kb using plasmid pRS426GPD-PSA1 as a template. The forward and reverse primers both have 
65 base-overhangs which are the homology immediately outside the target sequence. The site of 
integration for PSA1 is the upstream region of THI72 gene. Then, the gRNA plasmid containing 
the target sequence of the THI72 site constructed previously (Zhang et al., in preparation) 
together with the repair DNA of the PSA1 expression cassette were transformed into the D452-2 
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expressing Cas9, gmd, and wcaG to generate the D452-2 expressing gmd, wcaG, and an extra 
copy of PSA1 (D452-2 gmd wcaG PSA1) in the genome without disrupting any native genes.   
 The next gene target to increase the cytosolic level of GDP-D-mannose is GDA1. To 
deactivate GDA1, the repair DNA of 147 bp was designed to contain a stop codon, TAA, to 
prevent any gene transcription followed by random 30 bases replacing the whole ORF of GDA1 
gene. The primers (∆GDA1-donor_F and ∆GDA1-donor_R) amplifying the repair DNA have 57 
base-overhangs each which are the homology immediately before and after the GDA1 ORF. The 
gRNA plasmid targeting GDA1 was constructed using the gRNA plasmid for THI72 (Zhang et 
al., in preparation) as a backbone template. The primers (GDA1-gRNA_F and GDA1-gRNA_R) 
with the overhanging target sequences for GDA1 were exploited to amplify the template plasmid 
and create a new circular plasmid pRS42K-gRNA-GDA1. Then, the repair DNA for ∆GDA1 and 
the GDA1 gRNA were transformed into the D452-2 expressing Cas9, gmd, and wcaG to generate 
the D452-2 ∆GDA1 expressing gmd and wcaG (D452-2 gmd wcaG ∆GDA1). 
 To evaluate the effect of both PSA1 and ∆GDA1 on GDP-L-fucose synthesis, the D452-2 
gmd wcaG strain with double mutations of PSA1 and ∆GDA1 was created. The repair DNA of 
2.2 kb including the PSA1 expression cassette (GPDp-PSA1-CYC1t) was PCR amplified using 
plasmid pRS426GPD-PSA1 as a template. The primers (PSA1::∆GDA1-donor_F and 
PSA1::∆GDA1-donor_R) have 60 base-overhangs each which are the sequences instantly 
upstream and downstream of the GDA1 gene. Then, the repair DNA of the PSA1 expression 
cassette along with the GDA1 gRNA were transformed into the D452-2 expressing Cas9, gmd, 
and wcaG to generate the D452-2 ∆GDA1 expressing gmd, wcaG, and an additional copy of 
PSA1 (D452-2 gmd wcaG PSA1::∆GDA1) in the genome. 
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 Primers, plasmids, and strains used in this work are listed in Tables 5.1, 5.2, and 5.3, 
respectively. 
 
5.2.3 Media, culture conditions, and yeast transformation 
 For plasmid amplification, E. coli was grown overnight in lysogeny broth (LB) medium 
(10 g/L NaCl, 5 g/L yeast extract, and 10 g/L tryptone) containing 100 µg/mL of ampicillin at 
37ºC and 250 rpm. In terms of yeast transformation, the transformants were selected using an 
amino acid auxotrophic marker on yeast synthetic complete (YSC) medium (MP Biomedicals, 
Santa Ana, CA, USA) agar plate containing 6.7 g/L Yeast Nitrogen Base, 20 g/L glucose, 20 g/L 
agar, and 0.69 g/L of CSM (MP Biomedicals) which comprises appropriate amino acids. In 
regard to Cas9 transformation, the transformants were selected using an antibiotic marker on 
yeast extract-peptone (YP) medium (10 g/L yeast extract and 20 g/L peptone) agar plate 
containing 20 g/L glucose and 20 g/L agar supplemented with appropriate antibiotics. All yeast 
transformations related to expression of episomal vectors and Cas9-induced genome 
modification were executed by the high-efficiency yeast transformation method involving the 
usage of lithium acetate, polyethylene glycol, and single-stranded carrier DNA as described in 
Gietz and Schiestl (2007). For shake flask fermentation, the engineered yeast cells were 
cultivated in either YSC medium with suitable amino acids and 40 g/L of a carbon source 
(glucose, mannose, galactose, or lactose) or YP medium with 40 g/L of the carbon source. The 
flasks were incubated at 30ºC and 300 rpm.  
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 5.2.4 Fermentation experiments 
 The engineered yeast cells were first grown in either YSC medium with appropriate 
amino acids or YP medium containing 20 g/L of glucose in a 5 mL-volume culture tube to 
prepare inoculums for main shake flask fermentation. Cells were harvested at mid-exponential 
phase and inoculated in the main fermentation after a complete removal of the previous 
supernatant. All flask fermentation experiments were performed using 25 mL of either YSC 
medium or YP medium containing the tested carbon source in 125 mL flask with an initial 
optical density (OD) at 600 nm of the cell concentration adjusted to 1.0 (corresponding to 
approximately 0.3 g/L dry cell mass) under aerobic condition. A small amount of culture broth 
was sampled periodically during fermentation to monitor cell growth, metabolite changes, and 
GDP-L-fucose production. The first portion of culture broth was diluted with water to get a 
proper reading of the OD value representing the cell growth. The second portion of culture broth 
was centrifuged to separate the supernatant and the cells. The supernatant was appropriately 
diluted and subjected to extracellular metabolite analysis. For further intracellular GDP-L-fucose 
measurement, the leftover supernatant was carefully discarded. Then, the cell pellet was washed 
twice and resuspended with water of the same volume as the culture prior to centrifugation. The 
cell suspension was vigorously vortexed in the presence of glass beads for about 40 min to break 
the cells. Finally, the cell suspension was adequately centrifuged, and the cell lysate was 
subjected to GDP-L-fucose analysis.  
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5.2.5 Fucosyltransferase activity assay (In vitro synthesis of 2-FL) 
 Yeast cells grown to mid-log phase at 30ºC in YSC medium with 20 g/L of glucose and 
appropriate amino acids were harvested by centrifugation at 4,000 rpm and 4ºC for 5 min. The 
cell pellet was washed with cocktail buffer (25 mM Tris-HCl pH 7.5, 1 mM Dithiothreitol 
(DTT), and one cOmplete tablet (a protease inhibitor; F. Hoffmann-La Roche Ltd.) per 50 mL 
buffer) and resuspended in the same buffer. The cell suspension was vortexed vigorously in the 
presence of glass beads for 30 sec and then rested on ice for 30 sec. The process was repeated 
back and forth for the total time of 20 min. The cell suspension was centrifuged at 14,000 rpm 
and 4ºC for 10 min to completely remove cell debris. The supernatant is the crude extract 
expected to contain the intracellular enzymes including the fucT2 in the engineered yeast cells. 
 The fucosyltransferase assay was conducted to confirm the functional expression of 
FucT2 in S. cerevisiae. The assay reaction of 100 µL comprises 1.5 mM GDP-L-fucose, 2 mM 
lactose, 50 µL of the crude extract prepared formerly, 1 mM DTT, 1 U alkaline phosphatase, and 
an assay buffer (25 mM Tris, 150 mM NaCl, 10 mM MnCl2, and 5 mM CaCl2, pH 7.5). The 
reaction solution was incubated statically at 30°C. Samples were taken every 2-3 hours until 
GDP-L-fucose and lactose depleted. Usually, 3 µL of the solution was drawn from the reaction 
tube and diluted 100 times with water. The diluted reaction was subjected to heating at 95°C for 
5 min to halt the enzyme activity. Then, the sample was centrifuged at a high speed for 1 min to 
eliminate any potential debris after heating. The supernatant was submitted for analysis of GDP-
L-fucose, lactose, and 2-FL through chromatographic methods.  
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5.2.6 Analytical methods 
Cell concentration was measured as the optical density (OD) value at 600 nm using a 
spectrophotometer (Biomate 5, Thermo, NY, USA). Concentrations of glucose, mannose, 
galactose, and lactose in fermentation experiments were determined using a high performance 
liquid chromatography (HPLC) system (Agilent Technologies 1200 Series) equipped with the 
refractive index detector using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., 
Torrance, CA, USA). The column was eluted with 0.005 N of H2SO4 at a flow rate of 0.6 
mL/min at 50ºC. GDP-L-fucose concentration was measured using the HPLC system (Beckman 
Coulter System Gold composed of 508 Autosampler, 126 Solvent module, and 168 Detector) set 
up with the diode array detector using a CAPCELL PAK C18 MG column (250×4.6 mm, 
Shiseido, Tokyo, Japan). The column was eluted at a flow rate of 0.6 mL/min with 98% (v/v) of 
20 mM triethylamineacetate at pH 6.0 and 2% of acetonitrile. GDP-L-fucose was monitored by 
absorbance at 254 nm.  
 
5.3 Results 
 To empower S. cerevisiae to produce 2-FL, at least three aspects of genetic modification 
need to be executed including introduction of gmd and wcaG enzymes required to convert GDP-
D-mannose to GDP-L-fucose, incorporation of a lactose transporter needed to bring lactose into 
the cytosol, and introduction of fucT2 catalyzing the transfer reaction of L-fucose from GDP-L-
fucose onto lactose.   
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 5.3.1 Production of GDP-L-fucose in engineered S. cerevisiae 
 Plasmids pRS423GPD-gmd and pRS425GPD-wcaG for expressions of GMD and WcaG, 
respectively, were transformed into S. cerevisiae D452-2. The D452-2 transformants harboring 
gmd and wcaG genes were tested for GDP-L-fucose production in a shake flask fermentation in 
the presence of 20 g/L of the three different carbon sources (glucose, mannose, and galactose) 
(Fig. 5.3). Glucose and mannose seemed to be better substrates leading to higher GDP-L-fucose 
concentrations (about 1-1.5 mg product per 1 g cell weight). However, a galactose culture only 
produced about half of the amount of GDP-L-fucose (about 0.5 mg product per 1 g cell weight) 
produced in glucose and mannose conditions. Additionally, expressions of both GMD and WcaG 
are necessary to acquire GDP-L-fucose. Single expression of GMD or WcaG is not sufficient to 
gain GDP-L-fucose (data not shown). 
  
5.3.2 Effects of PSA1 overexpression and GDA1 knockout on GDP-L-fucose production  
 To enhance GDP-L-fucose synthesis in S. cerevisiae, further genetic perturbations may 
be required. The concentration of GDP-D-mannose is a crucial factor impacting GDP-L-fucose 
formation as GDP-D-mannose is a direct substrate to produce GDP-L-fucose. Thus, any genetic 
modification which can increase the GDP-D-mannose pool is anticipated to benefit GDP-L-
fucose production. PSA1 and GDA1 are among interesting gene targets because they relate to 
GDP-D-mannose synthesis and the consumption pathway of GDP-D-mannose, respectively. In 
this part of study, construction of S. cerevisiae capable of producing GDP-L-fucose using 
CRISPR-Cas genome-editing approach was demonstrated. The expression cassettes of gmd and 
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wcaG genes were integrated into the chromosome of S. cerevisiae D452-2 as a basal strain. 
Then, an additional copy of PSA1 gene was integrated into the basal strain to examine the effect 
of PSA1 overexpression. Next, GDA1 gene was deleted from the genome of the basal strain to 
explore the impact of GDA1 knockout. The combined effects of the two mutations (PSA1 and 
∆GDA1) were also investigated. 
 GDP-L-fucose production was evaluated in D452-2 gmd wcaG with different mutations 
in a shake flask fermentation in the presence of 40 g/L mannose (Fig. 5.4). As expected, the 
parental D452-2 was not able to produce any GDP-L-fucose. The D452-2 gmd wcaG basal strain 
produced 2.2 mg of GDP-L-fucose per 1 g cell weight. In the basal strain with an extra copy of 
PSA1 in the genome, 1.9 mg of GDP-L-fucose per 1 g cell weight was synthesized. An enhanced 
GDP-L-fucose production was noticed in the basal strain with GDA1 knockout. 3.5 mg of GDP-
L-fucose per 1 g cell weight was observed. However, no synergistic effect was detected in the 
basal strain with both PSA1 and GDA1 modifications. A similar amount of GDP-L-fucose 
formation of 3.6 mg per 1 g cell compared to the strain with GDA1 deletion only was observed. 
In summary, PSA1 overexpression did not have a positive effect on GDP-L-fucose improvement, 
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5.3.3 Construction of S. cerevisiae capable of assimilating lactose  
  S. cerevisiae wild-type does not assimilate lactose. Therefore, introduction of a lactose 
permease and a β-galactosidase into S. cerevisiae is necessary to attain lactose metabolism. Two 
candidates for a lactose transporter (LAC12 from K. lactis and CDT-1 from N. crassa) and two 
candidates for a lactose-hydrolyzing enzyme (LAC4 from K. lactis and GH1-1 from N. crassa) 
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were paired up in four possible combinations and assessed for their lactose-utilizing ability in S. 
cerevisiae D452-2 (Fig. 5.5). When 40 g/L lactose was provided to the cells in a shake flask 
fermentation, all four strains were able to consume lactose ranging from 9-17 g/L. LAC4 paired 
with any tested lactose transporter seemed to result in a better lactose consumption (at least 15 
g/L). GH1-1, an original β-glucosidase, was proved to also have a β-galactosidase activity. When 
GH1-1 was matched with CDT-1, lactose was more efficiently assimilated than GH1-1 matched 
with LAC12 (14.6 vs. 9.6 g/L).  
 
5.3.4 Functional expression of FucT2 in S. cerevisiae 
 FucT2 from H. pylori strain 26695 has been exploited extensively in 2-FL production in 
E. coli (Albermann et al., 2001; Baumgartner et al., 2013; Chin et al., 2015; Drouillard et al., 
2006; Lee et al., 2012a). Hence, it was selected as the first candidate in search of FucT2 which 
can functionally express in S. cerevisiae. In addition, FucT2 from a different strain of H. pylori 
(UA802) was chosen as the second candidate. FucT2 UA802 enzyme was characterized early at 
the same time as FucT2 26695 (Wang et al., 1999a,b), but has not been widely experimented in 
the context of 2-FL synthesis. Plasmids pRS426GPD-fucT2-26695 and pRS426GPD-fucT2-
UA802 were constructed and transformed into S. cerevisiae D452-2 individually. The in vitro 
synthesis of 2-FL was assayed using a standard GDP-L-fucose, lactose, and the crude extract of 
D452-2 expressing fucT2. Interestingly, the findings indicated the functional expression of 
FucT2 UA802 in D452-2, but not FucT2 26695. After 12 h of the reaction, 2-FL was detected in 
the assay containing the FucT2 UA802 lysate. The amount of the produced 2-FL equaled 0.4 
mM from the initial substrates of 1.5 mM GDP-L-fucose and 2 mM lactose.  
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5.4 Discussion 
 S. cerevisiae is a GRAS and beneficial microorganism in the food industries. It has been 
largely employed in alcoholic beverage fermentations and baked products. To further add value 
to this yeast, S. cerevisiae can be genetically modified to produce health-promoting products.    
2-FL is a human milk oligosaccharide which may strengthen a gut health by supporting the 
growth of Bifidobacteria and preventing the attachment of pathogens. Therefore, it may be 
worthwhile to extend the ability of S. cerevisiae to produce a functional compound such as 2-FL 
since 2-FL can be incorporated in the products created by this yeast and provides health benefits 
to consumers. 
 To construct S. cerevisiae capable of producing 2-FL, the primary to-do tasks consist of 
introduction of gmd and wcaG to convert the inherent GDP-D-mannose to GDP-L-fucose, 
internalization of lactose into the cytosol for 2-FL conversion, and expression of fucT2 which 
catalyzes the synthesis of 2-FL. In the first task, expression of gmd and wcaG permitted the 
production of GDP-L-fucose with the highest level of production in glucose as a carbon source. 
Mannose which came the second in the amount of the produced GDP-L-fucose was initially 
thought to be better than glucose. Mannose is closer to GDP-D-mannose in the metabolic 
pathway, but apparently a bigger proportion of carbon fluxes from mannose must have gone 
back to fructose-6-phosphate and the central metabolism rather than proceeding to the production 
of GDP-D-mannose. Nevertheless, mannose may be more suitable to use in the yeast strain 
intended for 2-FL production than glucose. Glucose may inhibit the uptake of lactose which is 
required to be internalized for 2-FL conversion. Glucose is the preferred sugar by the yeast so the 
uptake of other sugars is normally repressed during glucose metabolism. For future studies, other 
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sugar sources may be attempted. Mannose is relatively expensive and may not be a great choice 
for a large-scale fermentation. Xylose, for example, is cheap and has been researched to be 
superior to glucose to produce products other than ethanol (Kwak et al., in preparation). 
 In an effort to improve GDP-L-fucose production through further genetic perturbations, 
the effects of PSA1 overexpression and GDA1 deletion on GDP-L-fucose formation were 
explored. Overexpression of PSA1 which catalyzes the last step of GDP-D-mannose synthesis 
did not have a positive effect on GDP-L-fucose enhancement. On the other hand, deletion of 
GDA1 which involves in the golgi import of GDP-D-mannose led to an increase in GDP-L-
fucose production by 50%. Although a previous study reported an elevated level of GDP-D-
mannose through PSA overexpression (Janik et al., 2003), it is likely that the surplus GDP-D-
mannose was not utilized for GDP-L-fucose synthesis, but for production of other mannose-
containing compounds. Many types of mannosyltransferases exist for different purposes which 
compete for GDP-D-mannose and take away most of GDP-D-mannose from GDP-L-fucose 
production. However, disruption of these competitive pathways may not be very helpful because 
these enzymes localize in the golgi but GDP-L-fucose synthesis takes place in the cytosol. Also, 
it is difficult to knock out some mannosyltransferases since most of the knockouts can be lethal 
to the cells. Thus, an indirect gene target like GDA1 is more plausible in this situation since its 
deletion is not detrimental to the cell viability (Dean et al., 1997). Deletion of GDA1 improves 
GDP-L-fucose formation because more GDP-D-mannose is available in the cytosol for GDP-L-
fucose conversion. Owing to the insufficiency of GMP in the GDA1 null mutant, a significant 
portion of GDP-D-mannose cannot travel to the golgi so it accumulates more in the cytosol.  
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The second task to complete toward 2-FL production in S. cerevisiae is internalization of 
lactose into the cytosol. To achieve this goal, expression of a lactose transporter is unavoidable. 
Ultimately, an intact lactose is desired for 2-FL conversion. Therefore, expression of a β-
galactosidase is unfavorable. A co-expression of FucT2 and the lactose transporter may be 
sufficient to bring lactose in the cells since the activity of FucT2 may promote the import of 
lactose required to produce 2-FL. In the engineered E. coli without the β-galactosidase, 2-FL can 
be made successfully in the presence of only the lactose permease (LacY) and FucT2 (Chin et 
al., 2015). However, it is uncertain whether the same situation can be expected in yeast. In this 
study, the lactose permease was tested together with the β-galactosidase to prepare for the worst 
case that expressions of the lactose permease and FucT2 are not enough to bring in lactose. The 
combination of LAC12 and GH1-1 caused the least amount of lactose consumed by the cells (10 
g/L) as compared with three other combinations which performed similarly to each other (15-17 
g/L). The possible explanation for LAC12-GH1-1 may be because GH1-1 is not originally the 
true β-galactosidase and so it may not work as well when paired with the lactose permease from 
a different species. Nevertheless, the LAC12-GH1-1 pair may be the best option to choose in the 
event that the β-galactosidase activity is needed since its lactose metabolism is minimal 
suggesting that more intact lactose is available for 2-FL production. 
The third task required to produce 2-FL in S. cerevisiae is expression of FucT2. FucT2 
from H. pylori strain 26695 has been successfully employed to produce 2-FL in E. coli since 
2001 (Albermann et al., 2001). However, a slight worry regarding the negative result by fucT2 
26695 in S. cerevisiae arose due to the genetic characteristic of this gene as described in Wang et 
al. (1999a). The FucT2 26695 sequence has consecutive 14 C bases and imperfect TAA repeats 
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in the middle of the gene causing the split of the sequence into two ORFs. In order to produce a 
functional protein, the FucT2 26695 relies solely on the perfect translational frameshift which 
does not always happen. According to this fact, it was doubtful about the functional expression 
of FucT2 26695 in S. cerevisiae. Another candidate of FucT2 from H. pylori strain UA802 was 
then evaluated. The sequence of FucT2 UA802 is complete with a single full-length ORF which 
should give a constant production of functional protein. As anticipated, FucT2 UA802 was 
functionally expressed in S. cerevisiae encouraging the synthesis of 2-FL, but not FucT2 26695. 
As the three elements necessary for 2-FL production in S. cerevisiae were confirmed 
separately, the combination of the three parts was attempted in one strain. Unfortunately, an in 
vivo 2-FL production in S. cerevisiae has not yet succeeded so far. It is predicted that some of the 
produced GDP-L-fucose may have been transported through a non-specific sugar nucleotide 
transporter into the golgi and L-fucose may have been fucosylated with an unknown acceptor 
molecule. Thus, the cytosolic GDP-L-fucose may not be enough for 2-FL production. Still, more 
investigations to better understand the yeast sugar nucleotide system are needed to verify this 
hypothesis and determine what is missing to produce 2-FL in S. cerevisiae. 
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5.5 Figures and tables 
 
Fig. 5.1 Scheme to produce 2’-fucosyllactose (2-FL) in S. cerevisiae. S. cerevisiae innately 
produces GDP-D-mannose as a mannose donor for various mannosylation reactions. In order to 
enable this yeast to produce 2-FL, at least three elements need to be accomplished. First, an 
intracellular GDP-L-fucose production must be achieved. This requires a heterologous 
expression of GDP-D-mannose-4,6-dehydratase (Gmd) and GDP-4-keto-6-deoxymannose 3,5-
epimerase 4-reductase (WcaG) which converts the inherent GDP-D-mannose to GDP-L-fucose. 
Second, lactose must be transported to the cytosol. The native S. cerevisiae cannot assimilate 
lactose. Therefore, an introduction of a lactose transporter from other organisms is necessary. A 
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lactose-hydrolyzing enzyme which breaks down lactose into glucose and galactose may also be 
needed. Third, α-1,2-fucosyltransferase (FucT2) must be functionally expressed in S. cerevisiae. 
An introduction of the heterologous FucT2 is required. These three components are fundamental 
to construct the S. cerevisiae capable of producing 2-FL. Furthermore, GDP-D-mannose 
pyrophosphorylase (PSA1) may be an interesting overexpression target to increase the 
intracellular pool of GDP-D-mannose. The higher availability of GDP-D-mannose may lead to 
an enhanced GDP-L-fucose synthesis. The other enzymes shown in the diagram are abbreviated 
as follows; PMI40, mannose-6-phosphate isomerase; SEC53, phosphomannomutase. Pi, GDP, 
and GTP denote phosphate, guanosine 5’-diphosphate, and guanosine 5’-triphosphate, 
respectively. 
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Fig. 5.2 Fate of GDP-D-mannose in S. cerevisiae. Once GDP-D-mannose is produced in the 
cytosol, it is then transported into the golgi body through an antiporter. GDP-D-mannose 
proceeds as a substrate for many kinds of mannosylation reactions and releases GDP. Guanosine 
diphosphatase (GDA1) catalyzes the conversion of free GDP to GMP. As GMP travels back to 
the cytosol through the same antiporter, more GDP-D-mannose is allowed to enter the golgi. 
With a goal to produce GDP-L-fucose, the translocation of GDP-D-mannose into the golgi is 
undesirable. Berninsone et al. (1994) reported that GDA1 knockout mutant had a 5-fold 
reduction in the rate of GDP-D-mannose entry into the golgi. Hence, GDA1 may be a good 
deletion target to enhance GDP-L-fucose production since GDA1 knockout results in a higher 
availability of cytosolic GDP-D-mannose needed to convert to GDP-L-fucose. 
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Fig. 5.3 GDP-L-fucose production by S. cerevisiae D452-2 harboring plasmids pRS423GPD-
gmd and pRS425GPD-wcaG from 20 g/L sugar. The amount of GDP-L-fucose produced by the 
engineered S. cerevisiae was compared in three different sugar substrates. Colors of the bar chart 
denote as follows; blue, glucose; green, mannose; orange, galactose. 
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Fig. 5.4 GDP-L-fucose production by S. cerevisiae D452-2 with different genetic perturbations 
from 40 g/L mannose. The D452-2 with gmd and wcaG integrated in the genome is the basal 
strain to produce GDP-L-fucose. Effects of PSA1 overexpression and GDA1 deletion in the basal 
strain on enhancement of GDP-L-fucose were examined. Colors of the bar chart denote as 
follows; purple, parental D452-2; blue, D452-2 gmd wcaG; green, D452-2 gmd wcaG PSA1; 
orange, D452-2 gmd wcaG ∆GDA1; red, D452-2 gmd wcaG PSA1::∆GDA1. 
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Fig. 5.5 Lactose consumption by S. cerevisiae D452-2 harboring different combinations of a 
lactose transporter (pRS423GPD-LAC12 or pRS423PGK-cdt-1) and a lactose-hydrolyzing 
enzyme (pRS425GPD-LAC4 or pRS425PGK-gh1-1). This experiment was conducted with the 
initial lactose of 40 g/L. The abbreviation and source of the enzymes are as follows; LAC12, 
lactose permease from K. lactis; CDT-1, lactose permease/cellodextrin transporter from N. 
crassa; LAC4, β-galactosidase from K. lactis; GH1-1, β-glucosidase from N. crassa. Colors of 
the bar chart denote different sets of protein expression as follows; blue, LAC12 and LAC4; 
green, LAC12 and GH1-1; orange, CDT-1 and LAC4; red, CDT-1 and GH1-1. 
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Fig. 5.6 The high performance liquid chromatography (HPLC) results of the in vitro test of 2-FL 
synthesis by S. cerevisiae D452-2 harboring pRS426GPD (control), pRS426GPD-fucT2-26695, 
and pRS426GPD-fucT2-UA802. The functional expression of fucT2 in D452-2 was investigated 
by adding the crude extract of the D452-2 expressing different fucT2 in the assay reaction 
comprising GDP-L-fucose and lactose. Production of 2-FL was analyzed after 12 h of the assay. 
Empty plasmid control, FucT2 26695 (two-ORF), and FucT2 UA802 (one-ORF) denote plasmid 
pRS426GPD without fucosyltransferase (fucT2) insertion, pRS426GPD with fucT2 from H. 
pylori strain 26695 which has the sequence in two ORFs, and pRS426GPD with fucT2 from H. 
pylori strain UA802 which has a single full ORF, respectively. 
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Table 5.1 List of primers used in this study 
Name Sequence of PCR primers (restriction sites are underlined) Source 
gmd_F (SpeI) 
5’-TCTAGAGCGGCCGCACTAGTGCCACCATGTCAAA  
AGTCGCTCTCATCAC-3’ 
E. coli K-12 
gmd_R (ClaI) 
5’-TCTAGAGCGGCCGCATCGATTTATGACTCCAGCG   
CGATCG-3’ 
wcaG_F (BamHI) 
5’-TCTAGAGCGGCCGCGGATCCGCCACCATGAGTAA 
ACAACGAGTTTTTATTGC-3’ 
E. coli K-12 
wcaG_R (HindIII) 
5’-TCTAGAGCGGCCGCAAGCTTTTACCCCCGAAAGC 
GGTCTT-3’ 
LAC12_F (SpeI) 
5’-TCTAGAGCGGCCGCACTAGTGCCACCATGGCAGA 
TCATTCGAGCAG-3’ K. lactis      
Y-8279 
LAC12_R (SalI) 
5’-TCTAGAGCGGCCGCGTCGACTTAAACAGATTCTG 
CCTCTG-3’ 
LAC4_F (SpeI) 
5’-TCTAGAGCGGCCGCACTAGTGCCACCATGTCTTG 
CCTTATTCCTGAGAAT-3’ K. lactis      
Y-8279 
LAC4_R (SalI) 
5’-TCTAGAGCGGCCGCGTCGACTTATTCAAAAGCGA 
GATCAAACTC-3’ 
fucT2-26695_F 
(BamHI) 
5’-AATGCCGGATCCAAAACTTTTAAGGTGGTGCAA-3’ 
H. pylori 
26695  fucT2-26695_R 
(ClaI) 
5’-AATGCCATCGATTTAAGCGTTATACTTTTGGGA-3’ 
fucT2-UA802_F 
(BamHI) 
5’-TCTACAGCGGCCGCGGATCCGCCACCATGGCCTT 
TAAGGTCGTCC-3’ H. pylori 
UA802 fucT2-UA802_R 
(ClaI) 
5’-TATAGAGCGGCCGCATCGATGGCATTATACTTTT 
GAGAC-3’ 
PSA1_F (BamHI) 
5’-TCTAGAGCGGCCGCGGATCCGCCACCATGAAAGG 
TTTAATTTTAGTCGGTGG-3’ S. cerevisiae 
D452-2  
PSA1_R (ClaI) 
5’-TCTAGAGCGGCCGCATCGATTCACATAATAATAG 
CTTCCTTTGGAAC-3’ 
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Table 5.1 (cont.)   
Name Sequence of PCR primers  Source 
gmd-donor_F  
5’-TGATTAATTCTATGTATACATAATATATCTATTGC         
TTTCTTTTCCTTTATTTTCAATATTATcagctatgaccatgatta 
cgccaagcgcgc-3’ 
E. coli K-12 
gmd-donor_R 
5’-CGTATCGCAAAGAAGCATCACAAGAAAAAGTAG 
TAACAAAGAGCATTATTTTTCCATTCCCTTGTgccaggg 
ttttcccagtcacgacgttgtaa-3’ 
wcaG-donor_F 
5’-AACCTCGAGGAGAAGTTTTTTTACCCCTCTCCA 
CAGATCcaggaaacagctatgaccatg-3’ 
E. coli K-12 
wcaG-donor_R 
5’-TAATTAGGTAGACCGGGTAGATTTTTCCGTAAC 
CTTGGTGTCtgtaaaacgacggccagt-3’ 
PSA1-donor_F 
5’-TGCCTTATTAATTTATATGGAAGACGAGATAATT 
CATTAATTAGTCTACTCGACTAGATGAAATAcagctat   
gaccatgattacgccaag-3’ S. cerevisiae 
D452-2 
PSA1-donor_R 
5’-AGAAATGAATTCTATTATGATAGCGAATGCAAA 
ATATTCGTCCACATTCTTTTATCTATTGTCTTggttttcc 
cagtcacgacgttgtaa-3’ 
∆GDA1-donor_F 
5’-GCGAACAGTTAAGGGTCCTCTCGAGAAGAAACA 
TTAAGACATCATCGCACAAAAAACtaatggcaaacagtcca 
aggtacgcttacaccg-3’ S. cerevisiae 
D452-2 
∆GDA1-donor_R 
5’-CCGCAATCTCCTCTTCCTTAATATACATGGGACG 
AAAAGCGGTGTCCATGTTCTTATcggtgtaagcgtaccttgga 
ctgtttgccatta-3’ 
PSA1::∆GDA1-
donor_F 
5’-TTGGCGAACAGTTAAGGGTCCTCTCGAGAAGAA 
ACATTAAGACATCATCGCACAAAAAACcagctatgacca 
tgattacgccaagcgcgc-3’ S. cerevisiae 
D452-2 
PSA1::∆GDA1-
donor_R 
5’-TCACCGCAATCTCCTCTTCCTTAATATACATGGG 
ACGAAAAGCGGTGTCCATGTTCTTATgccagggttttccca 
gtcacgacgttgtaa-3’ 
GDA1-gRNA_F 5’-TTTGAATGAATTGAACGATTgttttagagctagaaatagcaag-3’ S. cerevisiae 
D452-2 GDA1-gRNA_R 5’-AATCGTTCAATTCATTCAAAgatcatttatctttcactgcgga-3’ 
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Table 5.2 List of plasmids used in this study 
Name Description of plasmids  Source 
pRS423GPD HIS3, GPD promoter, CYC1 terminator, 2 μ origin, and Ampr 
Christianson 
et al., 1992 
pRS425GPD LEU3, GPD promoter, CYC1 terminator, 2 μ origin, and Ampr 
Christianson 
et al., 1992 
pRS426GPD URA3, GPD promoter, CYC1 terminator, 2 μ origin, and Ampr 
Christianson 
et al., 1992 
pRS423PGK HIS3, PGK1 promoter, CYC1 terminator, 2 μ origin, and Ampr 
Christianson 
et al., 1992 
pRS425PGK LEU3, PGK1 promoter, CYC1 terminator, 2 μ origin, and Ampr 
Christianson 
et al., 1992 
pRS423GPD-gmd pRS423GPD harboring gmd gene from E. coli K-12 This study 
pRS425GPD-wcaG pRS425GPD harboring wcaG gene from E. coli K-12 This study 
pRS423GPD-
LAC12 
pRS423GPD harboring LAC12 gene from K. lactis Y-8279 This study 
pRS425GPD-LAC4 pRS425GPD harboring LAC4 gene from K. lactis Y-8279 This study 
pRS423PGK-cdt-1 pRS423PGK harboring cdt-1 gene from N. crassa 
Oh et al., in 
preparation 
pRS425PGK-gh1-1 pRS425PGK harboring gh1-1 gene from N. crassa 
Oh et al., in 
preparation 
pRS426GPD-
fucT2-26695 
pRS426GPD harboring fucT2 gene from H. pylori 26695 This study 
pRS426GPD-
fucT2-UA802 
pRS426GPD harboring fucT2 gene from H. pylori UA802 This study 
pRS426GPD-PSA1 pRS426GPD harboring PSA1 gene from S. cerevisiae D452-2 This study 
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Table 5.2 (cont.) 
 
 
 
 
 
 
Name Description of plasmids  Source 
pRS41N-Cas9 
A single-copy plasmid harboring Cas9 with a nourseothricin 
marker 
Zhang et al., 
2014 
pRS41H-Cas9 
A single-copy plasmid harboring Cas9 with a hygromycin B 
marker 
Zhang et al., 
in preparation 
pRS42H-gRNA- 
SPB1-PBN1 
A multicopy plasmid containing the gRNA for SPB1-PBN1 site 
with a hygromycin B marker 
Lane et al., in 
preparation 
pRS42K-gRNA- 
CRH1-HIP1 
A multicopy plasmid containing the gRNA for CRH1-HIP1 site 
with a geneticin marker 
Xu et al., in 
preparation 
pRS42K-gRNA-
THI72 
A multicopy plasmid containing the gRNA for THI72 site with 
a geneticin marker 
Zhang et al., 
in preparation 
pRS42K-gRNA-
GDA1 
A multicopy plasmid containing the gRNA for GDA1 site with 
a geneticin marker 
This study 
 
 113 
 
 
 
 
 
 
 
Table 5.3 List of strains used in this study 
Name Description of strains Source 
D452-2 S. cerevisiae, MATα, LEU2, HIS3, URA3, and CAN1 
Hosaka et al., 
1992 
D452-2 gmd wcaG D452-2 with gmd and wcaG genes integrated in the genome This study 
D452-2 gmd wcaG 
PSA1 
D452-2 gmd wcaG with an additional copy of PSA1 gene in the 
genome 
This study 
D452-2 gmd wcaG 
∆GDA1 
D452-2 gmd wcaG with GDA1 gene deleted in the genome This study 
D452-2 gmd wcaG 
PSA1::∆GDA1 
D452-2 gmd wcaG with an additional copy of PSA1 gene in 
place of GDA1 gene deleted in the genome 
This study 
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CHAPTER VI           SUMMARY AND FUTURE STUDIES 
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6.1 Summary 
 In chapter II, the E. coli capable of producing 2-FL was first constructed. Two plasmids 
comprising pmBCGW harboring the enzymes in the pathway to GDP-L-fucose (manB, manC, 
gmd, and wcaG) and pHfucT2 harboring the α-1,2-fucosyltransferase (fucT2) from H. pylori 
strain 26695 were transformed into E. coli JM109(DE3) and BL21star(DE3). Fermentations of 
the engineered E. coli were performed on lactose as a sole carbon source. The slow lactose-
consuming JM109(DE3) strain utilized more lactose for 2-FL conversion whereas the fast 
lactose-consuming BL21star(DE3) strain utilized most lactose for cell growth. JM109(DE3) was 
chosen as a host strain for 2-FL production. In the batch fermentation with 14.5 g/L lactose, the 
engineered JM109(DE3) was able to produce 1.2 g/L of 2-FL.  
 In chapter III, the fermentation conditions used in 2-FL production by the engineered 
JM109(DE3) were optimized. The optimized batch fermentation conditions leading to the 
highest amount of 2-FL include preculture at 30ºC-main culture at 25ºC, 0.1 mM IPTG induction 
at the beginning of fermentation, and 10-15 g/L lactose concentration. The optimized production 
conditions were applied in a fed-batch fermentation. Four rounds of 15 g/L lactose were used for 
cell growth and 2-FL conversion in the fermentation. A final 2-FL titer of 4.3 g/L was achieved. 
 In chapter IV, three different fucT2 enzymes (fucT2 from H. pylori 26695, fucT2 from H. 
pylori UA802, and fucT2 from E. coli O126 (wbgL)) were compared to identify the fucT2 
leading to the highest amount of 2-FL. The engineered JM109(DE3) with fucT2 from H. pylori 
UA802 produced the highest amount of 2-FL (4.2 g/L) in the fed-batch fermentation. The high 
cell density culture fed-batch fermentations (glycerol only and glycerol-mannose feeding) were 
performed in an attempt to further increase the 2-FL titer. In this high cell density culture 
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experiment, the host strain for 2-FL production was changed to BL21star(DE3)∆lacZ because 
JM109(DE3) had difficulty growing to the high cell density due to the EPS-derived culture 
viscosity. The BL21star(DE3)∆lacZ expressing the best fucT2 from H. pylori UA802 was able to 
produce 9 g/L of 2-FL at the end of the fermentation in both glycerol only and glycerol-mannose 
conditions. Addition of mannose was not helpful to obtain an enhanced 2-FL production though 
it was shown previously to be a good co-substrate with lactose to get the highest amount of 2-FL. 
 In chapter V, the host to produce 2-FL was moved from E. coli to S. cerevisiae. Although 
a successful 2-FL production in S. cerevisiae was not attained, the minimum three elements 
required to produce 2-FL in S. cerevisiae were demonstrated. First, gmd and wcaG genes need to 
be introduced to produce GDP-L-fucose from the inherent GDP-D-mannose. Second, a lactose 
transporter is required to bring lactose into the cytosol. Third, fucT2 gene which can functionally 
express in S. cerevisiae needs to be introduced. Moreover, GDA1 gene involved in the transport 
of GDP-D-mannose into the golgi was identified as a deletion target to improve GDP-L-fucose 
production in S. cerevisiae.  
 
6.2 Future studies 
 In regard to production of 2-FL in engineered E. coli, improvement of the fucT2 
expression in a soluble fraction should be performed. As shown on the SDS-PAGE in chapter II, 
most of the fucT2 was expressed in inclusion bodies. If more fucT2 can be expressed in a soluble 
form, 2-FL production should be enhanced tremendously. Examples of future attempts include 
promoter and induction system alteration, and co-expression of fucT2 with molecular 
chaperones. Furthermore, new gene targets to increase the intracellular supply of GDP-L-fucose 
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should be identified. In the consumption pathway of GDP-L-fucose, many genes implicated in 
the colanic acid operon may be perturbed. Concerning EPS production by JM109(DE3), the 
mechanism of EPS secretion, the composition of EPS, and the control of EPS may be 
investigated to improve 2-FL production in JM109(DE3). About fucT2 enzyme, a large survey of 
fucT2 from more sources may be conducted. Protein expressions of different fucT2 should be 
compared to better understand their activities and select the best fucT2 possible to enhance 2-FL 
synthesis.  
 In regard to production of GDP-L-fucose and 2-FL in engineered S. cerevisiae, GDA1 
gene may be thoroughly analyzed to understand how its deletion actually affects the cytosolic 
concentration of GDP-D-mannose and enhances GDP-L-fucose synthesis. Other ways to further 
increase the cytosolic concentration of GDP-D-mannose should be investigated. Enhancement of 
GDP supply used in GDP-L-fucose synthesis may be attempted by overexpression of enzymes in 
guanosine nucleotides biosynthetic pathways. The competing pathways for GDP-D-mannose 
may be eliminated. Some mannosyltransferases which are not lethal to the cells may be disrupted 
(more deletion targets). Moreover, labeling experiments to check where the carbons from GDP-
D-mannose go to should be conducted as the data may be useful for future genetic modification 
and strain improvement.     
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